<SEC-DOCUMENT>0001140361-24-027021.txt : 20240521
<SEC-HEADER>0001140361-24-027021.hdr.sgml : 20240521
<ACCEPTANCE-DATETIME>20240521160140
ACCESSION NUMBER:		0001140361-24-027021
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240521
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240521
DATE AS OF CHANGE:		20240521

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NBT BANCORP INC
		CENTRAL INDEX KEY:			0000790359
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				161268674
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14703
		FILM NUMBER:		24969219

	BUSINESS ADDRESS:	
		STREET 1:		52 S BROAD ST
		CITY:			NORWICH
		STATE:			NY
		ZIP:			13815
		BUSINESS PHONE:		6073372265

	MAIL ADDRESS:	
		STREET 1:		52 S. BROAD STREET
		CITY:			NORWICH
		STATE:			NY
		ZIP:			13815
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20029559_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:nbtb="http://nbtbank.com/20240521" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_b6dd1f5dec3445bd94bb941f4c456a81" contextRef="c20240521to20240521" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_383c2a85fcbb41169334f36904c58c0f" contextRef="c20240521to20240521">0000790359</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="nbtb-20240521.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240521to20240521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790359</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-21</xbrli:startDate><xbrli:endDate>2024-05-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: left; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_3e0cb6323c684ccb8fe25aea1f31481d" contextRef="c20240521to20240521">8-K</ix:nonNumeric></div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_f3d7b6dfefa1472e93cc3c6ef16ecf30" contextRef="c20240521to20240521" format="ixt:date-monthname-day-year-en">May 21, 2024</ix:nonNumeric></div>

      <div style="text-align: left; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span></div>

        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_41fe7b7ad458440ca75c687a995d9283" contextRef="c20240521to20240521">NBT BANCORP INC.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.28%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_2b65bf96e4724c749ae122cbbefd6dc5" contextRef="c20240521to20240521" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_116916a2d46842c3b3902726321be122" contextRef="c20240521to20240521">000-14703</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33.28%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_8ee18dbbf03d4b43b1fa0d84669469bf" contextRef="c20240521to20240521">16-1268674</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.28%; vertical-align: top; font-size: 10pt;" rowspan="1">
              <div style="text-align: center; font-family: 'Times New Roman';">(State or other jurisdiction of incorporation or organization)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;" rowspan="1">
              <div style="text-align: center; font-family: 'Times New Roman';">(Commission File Number)</div>
            </td>

    <td style="width: 33.28%; vertical-align: top; font-size: 10pt;" rowspan="1">
              <div style="text-align: center; font-family: 'Times New Roman';">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_f4f5bc05263b471db875150b1161f1bf" contextRef="c20240521to20240521">52 South Broad Street</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_43ee6b0da5dd4e9f8f7e62764100fecf" contextRef="c20240521to20240521">Norwich</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_1835f7bf23364f2f9aae89fd9a82c140" contextRef="c20240521to20240521" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_85cf0c58bd5749db88242146f851c671" contextRef="c20240521to20240521">13815</ix:nonNumeric></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Address of principal executive offices, zip code)</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-family: 'Times New Roman'; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_0269ca767f094573bfc5242b5d195703" contextRef="c20240521to20240521">607</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_6d09f6dc82664002b6a1229cf0f314e6" contextRef="c20240521to20240521">337-2265</ix:nonNumeric></span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman';"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_44b7452af36f4957a7ee3183e9039b1c" contextRef="c20240521to20240521" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_3945786da8934dc5a2bbf3593c0eb21d" contextRef="c20240521to20240521" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman';"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_3858e1ddb73445f5a25220535bd1fd8a" contextRef="c20240521to20240521" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman';"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_6910fa4411a446d8b5a5f0b75de558ef" contextRef="c20240521to20240521" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 37%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of class</div>
            </td>

    <td style="width: 0.9%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 24.08%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Trading Symbol</div>
            </td>

    <td style="width: 0.84%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 37.18%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name of exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 37%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_e02ce21253cd4cc791ac0e93983b7937" contextRef="c20240521to20240521">Common Stock, par value $0.01 per share</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 0.9%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 24.08%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_b1f0de9bfb13418c957b22f5336cadf5" contextRef="c20240521to20240521">NBTB</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 0.84%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 37.18%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_07288b9acf084110b65cf5b6b2ac371b" contextRef="c20240521to20240521" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
        12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_6db47367dda74316a87f0106d2073375" contextRef="c20240521to20240521" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: left; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">NBT Bancorp Inc. 2024 Omnibus Incentive Plan</div>

        <div style="font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On May 21, 2024 (the &#8220;Effective Date&#8221;), at the 2024 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of NBT Bancorp Inc. (the &#8220;Company&#8221;), the
          stockholders of the Company approved the NBT Bancorp Inc. 2024 Omnibus Incentive Plan (the &#8220;2024 Plan&#8221;), which will replace the NBT Bancorp Inc. 2018 Omnibus Incentive Plan (the &#8220;2018 Plan&#8221;). The Board of Directors of the Company (the &#8220;Board&#8221;)
          approved the 2024 Plan on March 18, 2024.</div>

        <div style="font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Term</span><span style="font-size: 10pt;">. The 2024 Plan terminates
            automatically on May 20, 2034, which is the day before the tenth anniversary of the Effective Date, unless it is earlier terminated by the Board designated by the Board.</span></div>

        <div style="font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Eligibility</span><span style="font-size: 10pt;">. Awards may be made
            under the 2024 Plan to employees, officers, directors, consultants or advisers of the Company or any of its affiliates.</span></div>

        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Awards</span><span style="font-size: 10pt;">. The following types of
            awards may be made under the 2024 Plan, subject to limitations set forth in the 2024 Plan:</span></div>

        <div style="font-size: 10pt;"><br/>
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Options to purchase shares of common stock of the Company;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Stock appreciation rights;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Restricted stock;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Restricted stock units;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Unrestricted stock;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Dividend equivalent rights; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cash awards.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Shares Available for Issuance</span><span style="font-size: 10pt;">.
            Subject to adjustment as provided in the 2024 Plan, the maximum number of shares of common stock of the Company that are available for issuance under the 2024 Plan will be equal to the sum of (i) 750,000 shares of common stock, plus (ii) the
            number of shares of common stock that become available for grant due to forfeiture of awards outstanding under the 2018 Plan and any other prior plans.</span></div>

        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A description of the material terms of the 2024 Plan is set forth in Proposal 3 contained in the Company&#8217;s Definitive Proxy Statement for the Annual
          Meeting filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on April 5, 2024. The above description of certain terms of the 2024 Plan is qualified in all respects by the full text of the 2024 Plan, a copy of which is filed as Exhibit
          10.1 hereto and the terms of which are incorporated herein by reference. A copy of the form of restricted stock unit agreement is filed as Exhibit 10.2, the terms of which are incorporated herein by reference.</div>

        <div style="font-size: 10pt;"><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div>
        <div style="font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits</div>

        <div style="font-size: 10pt;"><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit </div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
              </div>
            </td>

    <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" colspan="1"><br/>
            </td>

    <td style="width: 89.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Description</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20029559_ex10-1.htm">10.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;" colspan="1"><br/>
            </td>

    <td style="width: 89.29%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">NBT Bancorp Inc. 2024 Omnibus Incentive Plan</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20029559_ex10-2.htm">10.2*</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;" colspan="1"><br/>
            </td>

    <td style="width: 89.29%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Form of Restricted Stock Unit Award Agreement</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;" colspan="1"><br/>
            </td>

    <td style="width: 89.29%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">*Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. NBT Bancorp Inc. agrees to furnish supplementally to the SEC a copy of any omitted schedule
        upon request by the SEC.</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-size: 10pt;"><br/>
        </span></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">NBT BANCORP INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Date: May 21, 2024</div>
            </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><span style="text-decoration: underline;">/s/ Annette L. Burns</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Annette L. Burns</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Executive Vice President and Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ef20029559_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <!--PROfilePageNumberReset%LCR%1%- % -%--><font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 10.1</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NBT BANCORP INC.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2024 OMNIBUS INCENTIVE PLAN</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
        </div>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TABLE OF CONTENTS</div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Page</u></div>
      <table cellspacing="0" cellpadding="0" border="0" id="z8bc22bc846a74d878a248c6de9513008" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">1.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">PURPOSE</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">2.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">DEFINITIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">3.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">ADMINISTRATION OF THE PLAN</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">6</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">3.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Committee.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">6<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">3.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Board.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">3.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Terms of Awards.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">3.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">No Repricing Without Stockholder Approval.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">3.5</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Deferral Arrangement.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">3.6</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">No Liability.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">3.7</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Share Issuance/Book-Entry.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">4.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">STOCK SUBJECT TO THE PLAN</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">4.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Number of Shares Available for Awards.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">4.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Adjustments in Authorized Shares.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">4.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Share Usage.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">5.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">EFFECTIVE DATE, DURATION AND AMENDMENTS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">5.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Effective Date and Term.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">5.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Amendment and Termination of the Plan.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">6.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">AWARD ELIGIBILITY AND LIMITATIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">6.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Eligible Grantees.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">6.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Successive Awards and Substitute Awards.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">6.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Limitation on Awards to Non-Employee Directors.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">7.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">AWARD AGREEMENT</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">8.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">TERMS AND CONDITIONS OF OPTIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">8.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Option Price.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">8.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Vesting.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">8.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Term.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">8.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Termination of Service.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">8.5</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Limitations on Exercise of Option.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">8.6</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Method of Exercise.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">8.7</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Rights of Holders of Options.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">8.8</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Delivery of Stock.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">8.9</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Transferability of Options.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">8.10</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Family Transfers.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">15</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">8.11</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Limitations on Incentive Stock Options.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">15</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">8.12</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Notice of Disqualifying Disposition.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">15</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- i -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8398389b254e40c18be1ee33ea2563b5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">9.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">15</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">9.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Right to Payment and SAR Exercise Price.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">15</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">9.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Other Terms.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">16</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">9.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Term.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">16</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">9.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Rights of Holders of SARs.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">16</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">9.5</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Transferability of SARs.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">16</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">9.6</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Family Transfers.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">17</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">10.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">TERMS AND CONDITIONS OF RESTRICTED STOCK AND STOCK UNITS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">17</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">10.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Grant of Restricted Stock or Stock Units.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">17</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">10.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Restrictions.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">17</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">10.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Restricted Stock Certificates.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">17</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">10.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Rights of Holders of Restricted Stock.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">18</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">10.5</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Rights of Holders of Stock Units.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">18</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">10.6</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Termination of Service.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">18</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">10.7</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Purchase of Restricted Stock and Shares of Stock Subject to Stock Units.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">18</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">10.8</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Delivery of Stock.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">19</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">11.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">TERMS AND CONDITIONS OF UNRESTRICTED STOCK AWARDS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">19</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">12.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">FORMS OF PAYMENT</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">19</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">12.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">General Rule.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">19</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">12.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Surrender of Shares of Stock.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">19</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">12.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Cashless Exercise.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">19</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">12.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Other Forms of Payment.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">20</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">13.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">TERMS AND CONDITIONS OF DIVIDEND EQUIVALENT RIGHTS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">20</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">13.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Dividend Equivalent Rights.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">20</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">13.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Termination of Service.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">20</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">14.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">TERMS AND CONDITIONS OF PERFORMANCE AWARDS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">20</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">14.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Grant of Performance Awards.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">20</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">14.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Value of Performance Awards.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">21</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">14.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Form and Timing of Payment of Performance Awards.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">21</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">14.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Evaluation of Performance.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">21</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">15.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">PARACHUTE LIMITATIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">22</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">16.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">REQUIREMENTS OF LAW</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">22</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">16.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">General.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">22</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">16.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Rule 16b-3.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">23</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">17.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">EFFECT OF CHANGES IN CAPITALIZATION</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">23</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">17.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Changes in Stock.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">23</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">17.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Reorganization in Which the Company Is the Surviving Entity Which does not Constitute a Corporate Transaction.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">24</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">17.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Corporate Transaction in which Awards are not Assumed.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">24</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">17.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Corporate Transaction in which Awards are Assumed.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">25</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">17.5</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Adjustments.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">26</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">17.6</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">No Limitations on Company.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">26</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- ii -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf14ca92ff99b43f6bd18aae8fb07754e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">18.</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">GENERAL PROVISIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">26</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">18.1</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Disclaimer of Rights.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">26</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">18.2</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Nonexclusivity of the Plan.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">27</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">18.3</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Withholding Taxes.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">27</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">18.4</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Captions.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">28</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">18.5</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Other Provisions.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">28</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">18.6</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Number and Gender.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">28</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">18.7</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Severability.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">28</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">18.8</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Governing Law.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman';">28</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">18.9</div>
            </td>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Section 409A of the Code.</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">28</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- iii -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%- % -%-->
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NBT BANCORP INC.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2024 OMNIBUS INCENTIVE PLAN</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">The Company sets forth herein the terms of its 2024 Omnibus Incentive Plan, as follows:</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8989fdc3ab26465aa92981bc8f983b2d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">PURPOSE</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Plan is intended to enhance the Company&#8217;s and its Affiliates&#8217; (as defined herein) ability to attract and retain highly
          qualified officers, directors, key employees, and other persons, and to motivate such persons to serve the Company and its Affiliates and to expend maximum effort to improve the business results and earnings of the Company, by providing to such
          persons an opportunity to acquire or increase a direct proprietary interest in the operations and future success of the Company. To this end, the Plan provides for the grant of stock options, stock appreciation rights, restricted stock, stock
          units, unrestricted stock, dividend equivalent rights and cash awards. Any of these awards may, but need not, be made as performance incentives to reward attainment of annual or long-term performance goals in accordance with the terms hereof.
          Stock options granted under the Plan may be non-qualified stock options or incentive stock options, as provided herein, except that stock options granted to non-employee directors and any consultants or adviser providing services to the Company
          or an Affiliate shall in all cases be non-qualified stock options.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf70d617d6cb14367b559db40d99de848" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">DEFINITIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For purposes of interpreting the Plan and related documents (including Award Agreements), the following definitions shall
          apply:</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.1</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Affiliate&#8221;</font> means, with respect to the Company, any company or other trade or business that controls, is controlled by or is under common control with the Company
            within the meaning of Rule 405 of Regulation C under the Securities Act, including, without limitation, any Subsidiary. For purposes of granting Options or Stock Appreciation Rights, an entity may not be considered an Affiliate if it results in
            noncompliance with Code Section 409A.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Applicable Law&#8221; </font>means the legal requirements relating to the Plan and the Awards under (a) applicable provisions of the Code, the Securities Act, the Exchange
            Act, any rules or regulations thereunder, and any other laws, rules, regulations, and government orders of any jurisdiction applicable to the Company or its Affiliates, (b) applicable provisions of the corporate, securities, tax, and other
            laws, rules, regulations, and government orders of any jurisdiction applicable to Awards granted to residents thereof, and (c) the rules of any stock exchange or securities market on which the Stock is listed, quoted or publicly traded.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Award&#8221;</font> means a grant of an Option, Stock Appreciation Right, Restricted Stock, Stock Unit, Unrestricted Stock, Dividend Equivalent Rights, or cash award<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>under the Plan.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Award Agreement&#8221;</font> means the written agreement between the Company and a Grantee that evidences and sets out the terms and conditions of an Award.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Benefit Arrangement&#8221;</font> shall have the meaning set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 15</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 1 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Board&#8221;</font> means the Board of Directors of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Cause&#8221;</font><font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>shall have the meaning set forth in an employment or other service agreement
            between a Grantee and the Company or an Affiliate, and in the absence of any such employment or service agreement or if such agreement does not define &#8220;cause,&#8221; shall mean, with respect to any Grantee and as determined by the Committee: (1)
            personal dishonesty, incompetence (which shall be measured against standards generally prevailing in the financial institutions industry), willful or gross misconduct with respect to the business and affairs of the Company or NBT Bank, National
            Association (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">NBT Bank</font>&#8221;), or with respect to any of their affiliates for which Grantee is assigned material responsibilities or duties; (2) willful neglect, failure, or
            refusal to carry out Grantee&#8217;s duties in a reasonable manner after a written demand for substantial performance is delivered to Grantee that specifically identifies the manner in which the Company believes that Grantee has not substantially
            performed Grantee&#8217;s duties and Grantee has not resumed such substantial performance within 21 days of receiving such demand; (3) material violation of a Company or NBT Bank policy; (4) willful violation of any law, rule, or regulation (other
            than traffic violations or similar offenses), the commission of any act of fraud or embezzlement or conviction of (or plea of <font style="font-family: 'Times New Roman'; font-style: italic;">nolo contendere</font> to) a felony, whether or not
            committed in the course of Grantee&#8217;s employment with the Company, NBT Bank or any of their affiliates; (5) being a specific subject of a final cease and desist order form, written agreement with, or other order or supervisory direction from,
            any federal or state regulatory authority; (6) conduct tending to bring the Company, NBT Bank or any of their affiliates into public disgrace or disrepute; or (7) breach of any representation or warranty under Grantee&#8217;s employment agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Code&#8221;</font> means the Internal Revenue Code of 1986, as now in effect or as hereafter amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Committee&#8221;</font> means a committee of, and designated from time to time by resolution of, the Board, which shall be constituted as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.1.2</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Company&#8221;</font> means NBT Bancorp Inc., a Delaware corporation, and its successors and assigns.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Corporate Transaction&#8221;</font> means:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any Person hereafter becomes the &#8220;Beneficial Owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 30 percent or more of the combined voting power of the Company&#8217;s voting securities; or</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">During any period of two consecutive years, individuals who at the beginning of such period constitute the Board cease for any reason to constitute at least a majority thereof unless the election, or the nomination for election by the
              Company&#8217;s stockholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of the period; or</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 2 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">There shall be consummated (i) any transaction which results in any Person owning 50% or more of the combined voting power of the Company&#8217;s voting securities (including without limitation a consolidation or merger of the Company in which
              the Company is not the continuing or surviving corporation or pursuant to which voting securities would be converted into cash, securities, or other property, other than a merger of the Company in which the holders of voting securities
              immediately prior to the merger have the same proportionate ownership of common stock of the surviving corporation immediately after the merger), or (ii) any sale, lease, exchange, or other transfer (in one transaction or a series of related
              transactions) of all, or substantially all of the assets of the Company, provided that any such consolidation, merger, sale, lease, exchange or other transfer consummated at the insistence of an appropriate banking regulatory agency shall not
              constitute a Corporate Transaction; or</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the consummation of the liquidation or dissolution of the Company.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.12</font><font style="font-size: 10pt;"> &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Disability&#8221;</font> means a disability by reason of any medically determinable physical or mental impairment that can be expected to result in death or expected to last
            for a continuous period of not less than twelve (12) months that (a) renders the Grantee unable to engage in any substantial gainful activity or (b) qualifies the Grantee for benefits payable under the Company&#8217;s long-term disability plan under
            which the Grantee is covered.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.13</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Dividend Equivalent Right&#8221;</font>&#160;means a right, granted to a Grantee under <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 13</font> hereof, to receive
            cash, Stock, other Awards or other property equal in value to dividends paid with respect to a specified number of shares of Stock, or other periodic payments.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.14</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Effective Date&#8221;</font> means May 21, 2024, the date of approval of the Plan by the Company&#8217;s stockholders.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.15</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Exchange Act&#8221;</font> means the Securities Exchange Act of 1934, as now in effect or as hereafter amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.16</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Fair Market Value&#8221;</font> means the value of a share of Stock, determined for purposes of the Plan as follows: (i) if on the Grant Date or other determination date the
            Stock is listed, quoted or publicly traded on an established national or regional stock exchange or securities market, the Fair Market Value of a share of Stock shall be the closing price of the Stock on such exchange or in such market on the
            Grant Date or such other determination date or, if no sale of Stock is reported for such trading day, on the next preceding day on which any sale shall have been reported; and (ii) if on the Grant Date or other determination date the Stock is
            not listed, quoted or publicly traded on an established national or regional stock exchange or securities market, the Fair Market Value of a share of Stock shall be the value of the Stock as determined by the Committee by the reasonable
            application of a reasonable valuation method, in a manner consistent with Code Section 409A.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.17</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Family Member&#8221;</font> means a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, mother-in-law,
            father-in-law, son-in-law, daughter-in-law, brother, sister, brother-in-law, or sister-in-law, including adoptive relationships, of the Grantee, any person sharing the Grantee&#8217;s household (other than a tenant or employee), a trust in which any
            one or more of these persons have more than fifty percent of the beneficial interest, a foundation in which any one or more of these persons (or the Grantee) control the management of assets, and any other entity in which one or more of these
            persons (or the Grantee) own more than fifty percent of the voting interests.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 3 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.18</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Grant Date&#8221;</font> means, as determined by the Committee, the latest to occur of<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>(i) the date as
            of which the Committee approves an Award, (ii) the date on which the recipient of an Award first becomes eligible to receive an Award under <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 6</font> hereof, or (iii) such
            other date as may be specified by the Committee.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.19</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Grantee&#8221;</font> means a person who receives or holds an Award under the Plan.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.20</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Incentive Stock Option&#8221;</font> means an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code, or the corresponding provision of any subsequently
            enacted tax statute, as amended from time to time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.21</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Non-Employee Director&#8221;</font> shall have the meaning set forth in Rule 16b-3 under the Exchange Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.22</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Non-qualified Stock Option&#8221;</font> means an Option that is not an Incentive Stock Option.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.23</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Option&#8221;</font> means an option to purchase one or more shares of Stock granted pursuant to the Plan.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.24</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Option Price&#8221;</font> means the exercise price for each share of Stock subject to an Option.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.25</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Other Agreement&#8221;</font> shall have the meaning set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 15</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.26</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Parachute Payment&#8221; </font>shall have the meaning set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 15</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.27</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Performance Award&#8221;</font> means an Award that vests in whole or in part subject to the attainment of performance goals over a performance period.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.28</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Person&#8221; </font>shall have the meaning set forth in Section 13(d)(3) of the Exchange Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.29</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Plan&#8221;</font> means this NBT Bancorp Inc. 2024 Omnibus Incentive Plan, as it may be amended and/or restated from time to time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.30</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Prior Plans&#8221;</font> means the NBT Bancorp Inc. 2018 Omnibus Incentive Plan, the NBT Bancorp Inc. 2008 Omnibus Incentive Plan, and the NBT Bancorp Inc. 1993 Stock Option
            Plan.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.31</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Purchase Price&#8221;</font> means the purchase price for each share of Stock pursuant to a grant of Restricted Stock or Unrestricted Stock.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.32</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Restricted Stock&#8221;</font> means shares of Stock granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 10</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.33</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;SAR Exercise Price&#8221;</font> means the per share exercise price of a SAR granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9</font>
            hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.34</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Securities Act&#8221;</font> means the Securities Act of 1933, as now in effect or as hereafter amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 4 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.35</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Service&#8221;</font> means service as a Service Provider to the Company or an Affiliate. Unless otherwise stated in the applicable Award Agreement, a Grantee&#8217;s change in
            position or duties shall not result in interrupted or terminated Service, so long as such Grantee continues to be a Service Provider to the Company or an Affiliate. Subject to the preceding sentence, whether a termination of Service shall have
            occurred for purposes of the Plan shall be determined by the Committee, which determination shall be final, binding and conclusive. If a Service Provider&#8217;s employment or other Service relationship is with an Affiliate and the applicable entity
            ceases to be an Affiliate, a termination of Service shall be deemed to have occurred when such entity ceases to be an Affiliate unless the Service Provider transfers his or her employment or other Service relationship to the Company or any
            other Affiliate.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.36</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Service Provider&#8221;</font> means an employee, officer or director of the Company or an Affiliate, or a consultant or adviser (who is a natural person) currently providing
            services to the Company or an Affiliate.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.37</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Share Limit&#8221; </font>shall have the meaning set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 4.1</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.38</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Stock&#8221;</font> means the common stock, par value $0.01 per share, of the Company. or any security into which shares of Stock may be changed or for which shares of Stock
            may be exchanged as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.39</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Stock Appreciation Right&#8221;</font> or <font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;SAR&#8221;</font> means a right granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.40</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Stock Unit&#8221;</font> means a bookkeeping entry representing the equivalent of one share of Stock granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 10</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.41</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Subsidiary&#8221;</font> means any &#8220;subsidiary corporation&#8221; of the Company within the meaning of Section 424(f) of the Code.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.42</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Substitute Awards&#8221;</font> means Awards granted upon assumption of, or in substitution for, outstanding awards previously granted by a company or other entity acquired by the Company
            or any Affiliate or with which the Company or any Affiliate combines.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.43</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Ten Percent Stockholder&#8221;</font> means an individual who owns more than ten percent (10%) of the total combined voting power of all classes of outstanding stock of the Company, its
            parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Section 424(d) of the Code shall be applied.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">2.44</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Unrestricted Stock&#8221;</font> means an award granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 11</font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 5 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.</td>
                <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">ADMINISTRATION OF THE PLAN</div>
                </td>
              </tr>

          </table>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Committee</font>.</font></font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">3.1.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">Powers and Authorities.</font></font></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Committee shall administer the Plan and shall have such powers and authorities related to the administration of the Plan
          as are consistent with the Company&#8217;s certificate of incorporation and bylaws and with Applicable Law, or otherwise provided in any charter of the Committee. Without limiting the generality of the foregoing, the Committee shall have full power and
          authority to take all actions and to make all determinations required or provided for under the Plan, any Award, or any Award Agreement and shall have full power and authority to take all such other actions and to make all such other
          determinations not inconsistent with the specific terms and provisions of the Plan which the Committee deems to be necessary or appropriate to the administration of the Plan, any Award, or any Award Agreement. The Committee shall also have the
          power and authority to recover any Award granted under the Plan in accordance with the Company&#8217;s Incentive Compensation Recovery Policy, its Supplemental Incentive Compensation Recovery Policy, or any other policy that the Company may adopt from
          time to time that provides for the recovery of incentive compensation from employees. All such actions and determinations shall be made by (a) the affirmative vote of a majority of the members of the Committee present at a meeting at which a
          quorum is present, or (b) the unanimous consent of the members of the Committee executed in writing or evidenced by electronic transmission in accordance with the Company&#8217;s certificate of incorporation and bylaws and Applicable Law. Unless
          otherwise expressly determined by the Board, the Committee shall have the authority to interpret and construe all provisions of the Plan, any Award, and any Award Agreement, and any such interpretation or construction, and any other determination
          contemplated to be made under the Plan or any Award Agreement, by the Committee shall be final, binding, and conclusive on all Persons, whether or not expressly provided for in any provision of the Plan, such Award, or such Award Agreement.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that the Plan, any Award, or any Award Agreement provides for any action to be taken by the Board or any
          determination to be made by the Board, such action may be taken or such determination may be made by the Committee constituted in accordance with this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.1</font> if the
          Board has delegated the power and authority to do so to such Committee.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">3.1.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Composition of the Committee</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Committee shall be a committee composed of not fewer than two (2) directors of the Company designated by the Board to
          administer the Plan. Each member of the Committee shall be (a) a Non-Employee Director and (b) an independent director in accordance with the rules of any stock exchange or securities market on which the Stock is listed, quoted or publicly
          traded; provided that any action taken by the Committee shall be valid and effective whether or not members of the Committee at the time of such action are later determined not to have satisfied the requirements for membership set forth in this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.1.2</font> or otherwise provided in any charter of the Committee. Without limiting the generality of the foregoing, the Committee may be the Compensation and Benefits
          Committee of the Board or a subcommittee thereof if the Compensation and Benefits Committee of the Board or such subcommittee satisfies the foregoing requirements.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 6 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">3.1.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Other Committees</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Board also may appoint one or more committees of the Board, each composed of one or more directors of the Company who
          need not be Non-Employee Directors, which (a) may administer the Plan with respect to Grantees who are not officers or directors of the Company, (b) may grant Awards under the Plan to such Grantees, and (c) may determine all terms of such Awards,
          in each case, subject, if applicable, to the requirements of Rule 16b-3 under the Exchange Act and the rules of any stock exchange or securities market on which the Stock is listed, quoted or publicly traded.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">3.1.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">Delegation by the Committee.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">To the extent permitted by Applicable Law, the Committee may, by resolution, delegate some or all of its authority with respect
        to the Plan and Awards to the President and Chief Executive Officer of the Company and/or any other officer of the Company designated by the Committee, provided that the Committee may not delegate its authority hereunder (a) to make Awards to
        directors of the Company, (b) to make Awards to Employees who are (i) named executive officers or (ii) officers of the Company who are delegated authority by the Committee pursuant to this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.1.4</font>, or (c) to interpret the Plan, any Award, or any Award Agreement. Any delegation hereunder will be subject to the restrictions and limits that the Committee specifies at the time of such delegation or thereafter.
        Nothing in the Plan will be construed as obligating the Committee to delegate authority to any officer of the Company, and the Committee may at any time rescind the authority delegated to an officer of the Company appointed hereunder and delegate
        authority to one or more other officers of the Company. At all times, an officer of the Company delegated authority pursuant to this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.1.4</font> will serve in such capacity
        at the pleasure of the Committee. Any action undertaken by any such officer of the Company in accordance with the Committee&#8217;s delegation of authority will have the same force and effect as if undertaken directly by the Committee, and any reference
        in the Plan to the &#8220;Committee&#8221; will, to the extent consistent with the terms and limitations of such delegation, be deemed to include a reference to each such officer.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Board</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Board, from time to time, may exercise any or all of the powers and authorities related to the administration and
          implementation of the Plan, as set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.1</font> and other applicable provisions of the Plan, as the Board shall determine, consistent with the Company&#8217;s certificate
          of incorporation and bylaws and Applicable Law.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Terms of Awards.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 99pt; margin-left: 9pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">3.3.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Committee Authority.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to the other terms and conditions of the Plan, the Committee shall have full and final authority to:</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">designate Grantees,</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">determine the type or types of Awards to be made to a Grantee,</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">determine the number of shares of Stock to be subject to an Award </font>or to which an Award relates<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">,</font></font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 7 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">establish the terms and conditions of each Award (including, but not limited to, the exercise price of any Option, the nature and duration of any restriction or condition (or
                provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture of an Award or the shares of Stock subject thereto, and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options</font>);<font style="font-family: 'Times New Roman';"> provided that notwithstanding the foregoing, dividends or Dividend Equivalent Rights declared or paid on or with respect to Awards shall not vest or become payable unless and until the shares
                underlying the Awards to which the dividends or Dividend Equivalent Rights apply become vested and nonforfeitable,</font></font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">prescribe the form of each Award Agreement evidencing an Award,</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">determine conclusively whether </font>a Corporate Transaction has occurred, the date of the occurrence of such Corporate Transaction, and any incidental matters relating thereto,</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">accelerate the vesting or lapse of restrictions with respect to any Award, and</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">subject to the limitation on repricing in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.4</font>, amend, modify, or supplement the terms of any outstanding Award. Such authority specifically includes the
              authority, in order to effectuate the purposes of the Plan but without amending the Plan, to modify Awards to eligible individuals who are foreign nationals or are individuals who are employed outside the United States to recognize
              differences in local law, tax policy, or custom. Notwithstanding the foregoing, no amendment, modification or supplement of any Award Agreement shall, without the consent of the Grantee, impair the Grantee&#8217;s rights under such Award Agreement.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: left; text-indent: 90pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">3.3.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Forfeiture; Recoupment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Committee may reserve the right
            in an Award Agreement to cause a forfeiture of the gain realized by a Grantee with respect to an Award thereunder on account of actions taken by, or failed to be taken by, such Grantee in violation or breach of, or in conflict with, any (i)
            employment agreement, (ii) non-competition agreement, (iii) agreement prohibiting solicitation of Employees or clients of the Company or an Affiliate, (iv) confidentiality obligation with respect to the Company or an Affiliate, (v) Company or
            Affiliate policy or procedure, (vi) other agreement, or (vii) other obligation of such Grantee to the Company or an Affiliate, as and to the extent specified in such Award Agreement. If the Grantee of an outstanding Award is an Employee of the
            Company or an Affiliate and such Grantee&#8217;s Service is terminated for Cause, the Committee may annul such Grantee&#8217;s outstanding Award as of the date of the Grantee&#8217;s termination of Service for Cause.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">All Awards granted pursuant to the
            Plan shall be subject to mandatory repayment by the Grantee to the Company (i) to the extent set forth in this Plan or an Award Agreement or (ii) to the extent the Grantee is, or in the future becomes, subject to (1) any Company or Affiliate
            &#8220;clawback&#8221; or recoupment policy that is adopted to comply with the requirements of any Applicable Law or otherwise, or (2) any Applicable Law which imposes mandatory recoupment, under circumstances set forth in such Applicable Law<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 8 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">No Repricing Without Stockholder Approval.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except in connection with a corporate transaction involving
            the Company (including, without limitation, any stock dividend, distribution (whether in the form of cash, shares of Stock, other securities, or other property), stock split, extraordinary dividend, recapitalization, Corporate Transaction,
            reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of shares of Stock, or other securities or similar transaction), the Company may not: (a) amend the terms of outstanding Options or SARs to reduce
            the Option Price or SAR Exercise Price, as applicable; (b) cancel or assume outstanding Options or SARs </font><font style="font-size: 10pt;">in exchange for or substitution of <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Options or SARs </font>with an Option Price or SAR Exercise Price, as applicable, that is less than the Option Price or SAR Exercise Price, as applicable, of the original Options or SARs; (c) cancel or assume outstanding Options or SARs
            with an Option Price or SAR Exercise Price, as applicable, above the current Fair Market Value in exchange for cash, Awards, or other securities, in each case, unless such action (i) is subject to and approved by <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the stockholders of the Company</font> or (ii) would not be deemed to be a repricing under the rules of any stock exchange or securities market on which the Stock is listed, quoted or publicly traded.</font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Deferral Arrangement</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Committee may permit or require the deferral of any
            payment pursuant to an Award into a deferred compensation arrangement, subject to such rules and procedures as it may establish, which may include provisions for the payment or crediting of interest or </font><font style="font-size: 10pt;">Dividend






            Equivalent Rights<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, including converting such credits into deferred Stock Units </font>and for restricting deferrals to comply with hardship distribution rules affecting
            tax-qualified retirement plans subject to Code Section 401(k)(2)(B)(IV);<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>provided that no Dividend Equivalent Rights may be granted in connection with, or related to, an
            Award of Options or SARs<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Any such deferrals shall be made in a manner that complies with Code Section 409A, including, if applicable, with respect to when a &#8220;separation from
              service&#8221; (as defined for purposes of Code Section 409A) occurs.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">No Liability</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">No member of the Board or of the Committee shall be liable for any action or determination made in good faith with respect to
          the Plan, any Award, or any Award Agreement. Notwithstanding any provision of the Plan to the contrary, neither the Company, an Affiliate, the Board, the Committee, nor any person acting on behalf of the Company, an Affiliate, the Board, or the
          Committee will be liable to any Grantee or to the estate or beneficiary of any Grantee or to any other Person by reason of any acceleration of income, or any additional tax (including any interest and penalties), asserted by reason of the failure
          of an Award to satisfy the requirements of Code Section 422 or Code Section 409A or by reason of Code Section 4999, or otherwise asserted with respect to the Award; provided, that this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.6</font> shall not affect any of the rights or obligations set forth in an applicable agreement between the Grantee and the Company or an Affiliate.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">3.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Share Issuance/Book-Entry</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding any provision of this Plan to the contrary, the issuance of the Stock under the Plan may be evidenced in such
          a manner as the Committee, in its discretion, deems appropriate, including, without limitation, book-entry or direct registration (including transaction advices) or issuance of one or more Stock certificates.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 9 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z4795874eb22048ec88f8b9dd5d1c4ca1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">STOCK SUBJECT TO THE PLAN</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">4.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Number of Shares Available for Awards</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Subject to such additional shares of Stock as shall be
            available for issuance under the Plan pursuant to </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 4.2</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, and subject to adjustment as provided in </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 17</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> hereof, the number of shares of Stock reserved for issuance under the Plan shall be equal to the sum of (i) 750,000 shares of Stock, plus (ii) </font><font style="font-size: 10pt;">the number of shares of
            Stock related to awards outstanding under the Prior Plans as of the Effective Date that thereafter terminate by expiration or forfeiture, cancellation, or otherwise without the issuance of such shares of Stock<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> (the &#8220;</font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Share Limit</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8221;). Stock issued or to
              be issued under the Plan shall be authorized and unissued shares of Stock, treasury shares of Stock, or any combination of the foregoing, as may be determined from time to time by the Board or by the Committee. Any of the shares of Stock
              reserved and available for issuance under the Plan may be used for any type of Award under the Plan, and any or all of the shares of Stock reserved for issuance under the Plan shall be available for issuance pursuant to Incentive Stock
              Options.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">4.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Adjustments in Authorized Shares</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Committee shall have the right to substitute or assume Awards in connection with mergers, reorganizations, separations,
          or other transactions to which Section 424(a) of the Code applies. Unless permitted by the rules of any stock exchange or securities market on which the Stock is listed, quoted or publicly traded, the Share Limit pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 4.1</font> shall not be increased by the number of shares of Stock subject to any such assumed awards and Substitute Awards. Shares available for issuance under a
          stockholder-approved plan of a business entity that is a party to such transaction (as appropriately adjusted, if necessary, to reflect such transaction) may be used for Awards under the Plan and shall not reduce the number of shares of Stock
          otherwise available for issuance under the Plan, subject to the rules of any stock exchange or securities market on which the Stock is listed, quoted or publicly traded.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">4.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Share Usage</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Shares covered by an Award shall be counted as used as of the Grant Date for purposes of calculating the number of shares of Stock available for issuance under <font style="font-family: 'Times New Roman'; font-weight: bold;">Section
                4.1</font>.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any shares of Stock that are subject to Awards will be counted against the Share Limit as one (1) share of Stock for every one (1) share of Stock subject to the Award; provided, the number of shares of Stock subject to an Award of
              SARs will be counted against the Share Limit as one (1) share of Stock for every one (1) share of Stock subject to such Award regardless of the number of shares of Stock actually issued to settle such SARs upon the exercise of the SARs.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 10 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If any shares covered by an Award under the Plan or any award outstanding under the Prior Plans as of the Effective Date are not purchased or are forfeited or expire, or if such award otherwise terminates without delivery of any Stock
              subject thereto or is settled in cash in lieu of shares, then the number of shares of Stock with respect to such award shall, to the extent of any such forfeiture, termination or expiration, again be available for making Awards under the
              Plan; provided, that any shares of Stock subject to an award granted under the Prior Plans shall be available for issuance under the Plan in the same amount as such shares were counted against the share limits set forth in the applicable
              Prior Plan (but not to exceed one (1) share of Stock for every one (1) share of Stock subject to such award).</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The number of shares of Stock available for issuance under the Plan will not be increased by the number of shares of Stock (i) tendered, withheld, or subject to an Award granted
                under the Plan surrendered in connection with the purchase of shares of Stock upon exercise of an Option, (ii) that were not issued upon the net settlement or net exercise of a Stock-settled SAR granted under the Plan, or (iii) purchased by
                the Company with proceeds from Option exercises. Any shares of Stock deducted or delivered from payment of an Award other than an Option or SAR granted under the Plan in connection with the Company&#8217;s tax withholding obligations as provided
                in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 18.3 </font>shall again be available for making Awards under the Plan in the same amount as such Shares were counted against the Share
              Limit<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8175b805273941b8a938223561456b67" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">EFFECTIVE DATE, DURATION AND AMENDMENTS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">5.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Effective Date and Term</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Plan shall be effective as of the Effective Date. Following the Effective Date, no awards will be made under the Prior
          Plans. Notwithstanding the foregoing, shares of Stock reserved under the Prior Plans to settle awards, including performance-based awards, which are made under the Prior Plans prior to the Effective Date may be issued and delivered following the
          Effective Date to settle such awards. The Plan shall terminate on the first to occur of (a) the day before the tenth (10th) anniversary of the Effective Date, (b) the date determined in accordance with <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 5.2</font>, and (c) the date determined in accordance with <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17.3</font>; provided, however, that Incentive Stock Options may not be
          granted under the Plan after the tenth (10th) anniversary of the date of the Board&#8217;s adoption of the Plan. Upon such termination of the Plan, all outstanding Awards shall continue to have full force and effect in accordance with the provisions of
          the terminated Plan and the applicable Award Agreement (or other documents evidencing such Awards).</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">5.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Amendment and Termination of the Plan</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Board may, at any time and from time to time, amend, suspend, or terminate the Plan; provided that with respect to Awards
          theretofore granted under the Plan, no amendment, suspension, or termination of the Plan shall, without the consent of the Grantee, impair rights or obligations under any such Award. An amendment shall be contingent on approval of the Company&#8217;s
          stockholders to the extent stated by the Board or required by Applicable Law; provided that no amendment shall be made to the no-repricing provisions of <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.4</font>, the
          Option Price provisions of <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.1</font>, or the SAR Exercise Price provisions of <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9.1</font> without
          the approval of the Company&#8217;s stockholders. In addition, an amendment will be contingent on approval of the Company&#8217;s stockholders if the amendment would: (i) materially increase the benefits accruing to participants under the Plan, (ii)
          materially increase the aggregate number of shares of Stock that may be issued under the Plan, or (iii) materially modify the requirements as to eligibility for participation in the Plan. No Awards shall be made under the Plan after termination
          of the Plan.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 11 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb287dc42022d4580b0a38d24bb33fdec" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">AWARD ELIGIBILITY AND LIMITATIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">6.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Eligible Grantees</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 6</font>, Awards may be made under
          the Plan to any Service Provider, as the Committee shall determine and designate from time to time.</div>
        <div style="font-size: 10pt;"><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">6.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Successive Awards and Substitute Awards.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.4</font>, Awards granted under the
          Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with, or in substitution or exchange for, (a) any other Award, (b) any award granted under another plan of the Company, an Affiliate, or any
          business entity that has been a party to a transaction with the Company or an Affiliate, or (c) any other right of a Grantee to receive payment from the Company or an Affiliate. Such additional, tandem, exchange, or Substitute Awards may be
          granted at any time. If an Award is granted in substitution or exchange for another Award, or for an award granted under another plan of the Company, an Affiliate, or any business entity that has been a party to a transaction with the Company or
          an Affiliate, the Committee shall require the surrender of such other Award or award under such other plan in consideration for the grant of such exchange or Substitute Award. In addition, Awards may be granted in lieu of cash compensation,
          including in lieu of cash payments under other plans of the Company or an Affiliate.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Sections 8.1</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> and </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.1</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, but subject to </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 3.4</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, the Option Price of an Option or the SAR Exercise Price of an SAR that is a Substitute Award may be less than
            100% of the Fair Market Value of a share of Stock on the original Grant Date; provided, that, the Option Price or SAR Exercise is determined in accordance with the principles of Code Section 424 and the regulations thereunder</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">for any Incentive Stock Option and consistent with Code Section 409A for any other Option or SAR.</font></font></div>
        <div style="font-size: 10pt;"><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">6.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Limitation on Awards to Non-Employee Directors.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During any time when the Company has a class of equity security registered under Section 12 of the Exchange Act, but subject
          to adjustment as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17 </font>herein, the maximum total fees and aggregate Grant Date Fair Market Value of shares of Stock that may be granted under the Plan that
          may be paid to or granted in a calendar year to a Non-Employee Director in connection with his or her services to the Board is $750,000; provided, however, that the foregoing limitation shall not apply (a) during the first year an individual is
          newly elected or appointed as a Non-Employee Director and (b) to the extent that a Non-Employee Director has been or becomes an employee of the Company during the calendar year.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 12 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1ad85c97f9b748b099a80b6d9a90cf7b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">AWARD AGREEMENT</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each Award granted pursuant to the Plan shall be evidenced by an Award Agreement, in such form or forms as the Committee
          shall from time to time determine. Award Agreements granted from time to time or at the same time need not contain similar provisions but shall be consistent with the terms of the Plan. Each Award Agreement evidencing an Award of Options shall
          specify whether such Options are intended to be Non-qualified Stock Options or Incentive Stock Options, and in the absence of such specification, such Options shall be deemed Non-qualified Stock Options. In the event of any inconsistency between
          the Plan and an Award Agreement, the provisions of the Plan shall control.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z208e2b4c50d54722b2949a78a50ef53d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">TERMS AND CONDITIONS OF OPTIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Option Price.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Option Price of each Option shall be fixed by the Committee and stated in the Award Agreement evidencing such Option. The
          Option Price of each Option shall be at least 100 percent of the Fair Market Value on the Grant Date of a share of Stock; provided, however, that in the event that a Grantee is a Ten Percent Stockholder, the Option Price of an Option granted to
          such Grantee that is intended to be an Incentive Stock Option shall be not less than 110 percent of the Fair Market Value of a share of Stock on the Grant Date. In no case shall the Option Price of any Option be less than the par value of a share
          of Stock.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Vesting</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to <font style="font-family: 'Times New Roman'; font-weight: bold;">Sections 8.3 and 17.3</font> hereof, each Option
          granted under the Plan shall become exercisable at such times and under such conditions as shall be determined by the Committee and stated in the Award Agreement; provided<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>that





          no Option shall be granted to Grantees who are entitled to overtime under Applicable Law that will vest or be exercisable within a six (6)-month period starting on the Grant Date. For purposes of this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.2</font>, unless otherwise determined by the Committee, fractional numbers of shares of Stock subject to an Option shall be rounded down to the next nearest whole number.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Term</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each Option granted under the Plan shall terminate, and all rights to purchase shares of Stock thereunder shall cease, upon
          the expiration of ten (10) years from the date such Option is granted, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Committee and stated in the Award Agreement relating to such
          Option; provided, however, that in the event that the Grantee is a Ten Percent Stockholder, an Option granted to such Grantee that is intended to be an Incentive Stock Option shall not be exercisable after the expiration of five years from its
          Grant Date; provided, further, that if expiration of the Option would occur during a period in which the Grantee is (a) subject to a lock-up agreement restricting the Grantee&#8217;s ability to sell shares of Stock in the open market or (b) restricted
          from selling shares of Stock in the open market because the Grantee is not then eligible to sell under the Company&#8217;s insider trading or similar plan as then in effect (whether because a trading window is not open or the Grantee is otherwise
          restricted from trading), the expiration of the Option will be delayed until 2&#189; months after the date such restriction ends.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 13 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Termination of Service.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each Award Agreement with respect to the grant of an Option shall set forth the extent to which the Grantee thereof, if at
          all, shall have the right to exercise such Option following the Grantee&#8217;s termination of service. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Options issued pursuant to the Plan, and
          may reflect distinctions based on the reasons for termination of Service.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Limitations on Exercise of Option.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding any other provision of the Plan, in no event may any Option be exercised, in whole or in part, prior to the
          date the Plan is approved by the stockholders of the Company as provided herein or after the occurrence of an event referred to in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17</font> hereof which results in
          termination of the Option.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Method of Exercise.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to the terms of <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 12</font>, an Option that
          is exercisable may be exercised by the Grantee&#8217;s delivery to the Company or its designee of written notice of exercise on any business day, at the Company&#8217;s principal office, on the form specified by the Company. Such notice shall specify the
          number of shares of Stock with respect to which the Option is being exercised and shall be accompanied by payment in full of the Option Price of the shares for which the Option is being exercised plus the amount (if any) of federal and/or other
          taxes which the Company may, in its judgment, be required to withhold with respect to such Option.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Rights of Holders of Options.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Unless otherwise stated in the applicable Award Agreement, a
            Grantee </font><font style="font-size: 10pt;">or other Person <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">holding or exercising an Option shall have none of the rights of a stockholder (for example, the right to receive
              cash or dividend payments or distributions attributable to the subject shares of Stock or to direct the voting of the subject shares of Stock subject to such Option, or to receive notice of any meeting of the Company&#8217;s stockholders) until the
              shares of Stock covered thereby are fully paid and issued to such Grantee or other Person. Except as provided in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 17</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> hereof, no adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date of such issuance of such shares of Stock.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Delivery of Stock.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Promptly after the exercise of an Option by a Grantee and the payment in full of the Option Price and all applicable taxes,
          such Grantee shall be entitled to receive such evidence of his or her ownership of the shares of Stock subject to the Option as shall be consistent with <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.7</font>.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Transferability of Options.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Except as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.10</font>, during the
          lifetime of a Grantee of an Option, only the Grantee (or, in the event of legal incapacity or incompetency, the Grantee&#8217;s guardian or legal representative) may exercise an Option. Except as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.10</font>, no Option shall be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 14 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Family Transfers</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If authorized in the applicable Award Agreement or by the Committee, a Grantee may transfer, not for value, all or part of an
          Option which is not an Incentive Stock Option to any Family Member. For the purpose of this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.10</font>, a &#8220;not for value&#8221; transfer is a transfer which is (a) a gift, (b) a
          transfer under a domestic relations order in settlement of marital property rights, or (c) a transfer to an entity in which more than fifty percent of the voting interests are owned by Family Members (or the Grantee) in exchange for an interest
          in that entity. Following a transfer under this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.10</font>, any such Option shall continue to be subject to the same terms and conditions as were applicable immediately
          prior to transfer. Subsequent transfers of transferred Options are prohibited except to Family Members of the original Grantee in accordance with this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section</font>&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">8.10</font> or by will or the laws of descent and distribution. The events of termination of Service of <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.4</font>
          hereof shall continue to be applied with respect to the original Grantee, following which the Option shall be exercisable by the transferee only to the extent, and for the periods specified, in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 8.4</font>.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Limitations on Incentive Stock Options</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">An Option shall constitute an Incentive Stock Option only (a) if the Grantee of such Option is an employee of the Company or
          any Subsidiary of the Company; (b) to the extent specifically provided in the related Award Agreement; and (c) to the extent that the aggregate Fair Market Value (determined as of the Grant Date) of the shares of Stock with respect to which all
          Incentive Stock Options held by such Grantee become exercisable for the first time during any calendar year (under the Plan and all other plans of the Grantee&#8217;s employer and its Affiliates) does not exceed $100,000. This limitation shall be
          applied by taking Options into account in the order in which they were granted.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">8.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Disqualifying Disposition</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Grantee shall make any disposition of shares of Stock issued pursuant to the exercise of an Incentive Stock Option
          under the circumstances described in Code Section 421(b) (relating to certain disqualifying dispositions), such Grantee shall notify the Company of such disposition within ten (10) days thereafter.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc89885f81cd24ce9832eb43b9c98d7c9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Right to Payment and SAR Exercise Price</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A SAR shall confer on the Grantee to whom it is granted a right to receive, upon exercise thereof, the excess of (a) the Fair
          Market Value of one share of Stock on the date of exercise over (b) the SAR Exercise Price as determined by the Committee. The Award Agreement for a SAR shall specify the SAR Exercise Price, which shall be at least 100 percent of the Fair Market
          Value of a share of Stock on the Grant Date of such SAR. SARs may be granted in tandem with all or part of an Option granted under the Plan or at any subsequent time during the term of such Option, in combination with all or any part of any other
          Award, or without regard to any Option or other Award; provided that a SAR that is granted in tandem with all or part of an Option will have the same term, and expire at the same time, as the related Option; provided, further, that a SAR that is
          granted subsequent to the Grant Date of a related Option must have a SAR Exercise Price that is no less than 100 percent of the Fair Market Value of one (1) share of Stock on the Grant Date of such SAR.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 15 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Other Terms</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to <font style="font-family: 'Times New Roman'; font-weight: bold;">Sections</font>&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">9.3</font> and <font style="font-family: 'Times New Roman'; font-weight: bold;">17.3</font>, the Committee <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">shall determine on the Grant Date or thereafter,
            (a) the time or times at which and the circumstances under which an SAR may be exercised in whole or in part (including based on achievement of performance goals and/or future service requirements), (b) the time or times at which SARs shall
            cease to be or become exercisable following termination of Service or upon other conditions, (c) the method of exercise, method of settlement, and form of consideration payable in settlement, (d) method by or forms in which Stock will be
            delivered or deemed to be delivered to Grantees, (e) whether or not a SAR shall be granted in tandem or in combination with any other Award, and (f) any and all other terms and conditions of any SAR; </font>provided<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>that no SARs shall be granted to Grantees who are entitled to overtime under Applicable Law that will vest or be exercisable within a six (6)-month period starting on the Grant Date<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Term</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each SAR granted under the Plan shall terminate, and all rights thereunder shall cease, upon the expiration of ten years from
          the Grant Date of such SAR, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Committee and stated in the Award Agreement relating to such SAR.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Rights of Holders of SARs</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless otherwise stated in the applicable Award Agreement, a Grantee or other Person holding or exercising a SAR shall have none of the rights of
          a stockholder of the Company (for example, the right to receive cash or dividend payments or distributions attributable to the shares of Stock underlying such SAR, to direct the voting of the shares of Stock underlying such SAR, or to receive
          notice of any meeting of the Company&#8217;s stockholders) until the shares of Stock underlying such SAR, if any, are issued to such Grantee or other Person. Except as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section





            17</font>, no adjustment shall be made for dividends, distributions, or other rights with respect to any shares of Stock underlying a SAR for which the record date is prior to the date of issuance of such shares of Stock, if any.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Transferability of SARs</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Except as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9.6</font>, during the
          lifetime of a Grantee, only the Grantee (or, in the event of legal incapacity or incompetency, the Grantee&#8217;s guardian or legal representative) may exercise a SAR. Except as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9.6</font>, no SAR shall be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 16 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">9.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Family Transfers</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If authorized in the applicable Award Agreement or by the Committee, a Grantee may transfer, not for value, all or part of a
          SAR to any Family Member. For the purpose of this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9.6</font>, a &#8220;not for value&#8221; transfer is a transfer which is (a) a gift, (b) a transfer under a domestic relations order
          in settlement of marital property rights, or (c) a transfer to an entity in which more than fifty percent of the voting interests are owned by Family Members (or the Grantee) in exchange for an interest in that entity. Following a transfer under
          this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 9.6</font>, any such SAR shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. Subsequent transfers of
          transferred SARs are prohibited except to Family Members of the original Grantee in accordance with this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section</font>&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">9.6</font> or by will or the laws of descent and distribution.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf8a8a4276d024ad1beaf217e9344c9fd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">TERMS AND CONDITIONS OF RESTRICTED STOCK AND STOCK UNITS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Grant of Restricted Stock or Stock Units</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Awards of Restricted Stock or Stock Units may be made for no consideration (other than par value of the shares which is
          deemed paid by past or future Service).</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Restrictions</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to <font style="font-family: 'Times New Roman'; font-weight: bold;">Sections 17.3 and 18.9</font>, at the time a
          grant of Restricted Stock or Stock Units is made, the Committee may, in its sole discretion, establish (a) a period of time (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">restricted period</font>&#8221;) applicable to such
          Restricted Stock or Stock Units and (b) prescribe restrictions in addition to or other than the expiration of the restricted period, including the satisfaction of corporate or individual performance objectives, which may be applicable to all or
          any portion of the Restricted Stock or Stock Units as described in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 14</font>. Each award of Restricted Stock or Stock Units may be subject to a different restricted period.
          Neither Restricted Stock nor Stock Units may be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the restricted period or prior to the satisfaction of any other restrictions prescribed by the Committee with
          respect to such Restricted Stock or Stock Units.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Restricted Stock Certificates</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.7</font>, to the extent that
          ownership of Restricted Stock is evidenced by a book-entry registration or direct registration (including transaction advices), such registration shall be notated to evidence the restrictions imposed on such Award of Restricted Stock under the
          Plan and the applicable Award Agreement. Subject to <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 3.7</font> and the immediately following sentence, the Company may issue, in the name of each Grantee to whom Restricted
          Stock has been granted, stock certificates representing the total number of shares of Restricted Stock granted to the Grantee, as soon as reasonably practicable after the Grant Date. The Committee may provide in an Award Agreement that either (a)
          the Secretary of the Company shall hold such certificates for the Grantee&#8217;s benefit until such time as the Restricted Stock is forfeited to the Company or the restrictions lapse, or (b) such certificates shall be delivered to the Grantee,
          provided, however, that such certificates shall bear a legend or legends that comply with Applicable Law and makes appropriate reference to the restrictions imposed under the Plan and the Award Agreement.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 17 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Rights of Holders of Restricted Stock</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Unless the Committee otherwise provides in an Award Agreement, holders of Restricted Stock shall have the right to vote such
          Stock and the right to receive any dividends declared or paid with respect to such Stock. The Committee may provide in an Award Agreement evidencing a grant of Restricted Stock that (a) any dividends paid on Restricted Stock must be reinvested in
          shares of Stock, which may or may not be subject to the same vesting conditions and restrictions applicable to such Restricted Stock or (b) any dividend payments or distributions declared or paid on shares of Restricted Stock shall only be made
          or paid upon satisfaction of the vesting conditions and restrictions applicable to such shares of Restricted Stock. Notwithstanding the foregoing, cash dividends declared or paid on shares of Restricted Stock shall not vest or become payable
          unless and until the shares of Restricted Stock to which the dividends apply become vested and nonforfeitable. All stock dividend payments or distributions, if any, received by a Grantee with respect to Restricted Stock as a result of any stock
          split, stock dividend, combination of shares, or other similar transaction shall be subject to the restrictions applicable to the original grant.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Rights of Holders of Stock Units</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">10.5.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Voting and Dividend Rights.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Grantees of Stock Units shall have no rights as stockholders
            of the Company (for example, the right to receive dividend payments or distributions attributable to the shares of Stock underlying such Restricted Stock Units, to direct the voting of the shares of Stock underlying such Restricted Stock Units,
            or to receive notice of any meeting of the Company&#8217;s stockholders). The Committee may provide in an Award Agreement evidencing a grant of Stock Units that the holder of such Stock Units shall be entitled to receive</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Dividend Equivalent Rights in accordance with </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 13.1</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: bold;">10.5.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Creditor&#8217;s Rights.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A holder of Stock Units shall have no rights other than those of a general unsecured creditor of the Company. Stock Units
          represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Award Agreement.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Termination of Service</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Unless the Committee otherwise provides in an Award Agreement or in writing after the Award Agreement is issued, upon the
          termination of a Grantee&#8217;s Service, any Restricted Stock or Stock Units held by such Grantee that have not vested, or with respect to which all applicable restrictions and conditions have not lapsed, shall immediately be deemed forfeited. Upon
          forfeiture of Restricted Stock or Stock Units, the Grantee shall have no further rights with respect to such Award, including but not limited to any right to vote Restricted Stock or any right to receive dividends or Dividend Equivalent Rights,
          as applicable, with respect to shares of Restricted Stock or Stock Units.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Purchase of Restricted Stock and Shares of Stock Subject to Stock Units</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Grantee</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">of an Award of Restricted Stock or vested RSUs shall be required, to the extent required by Applicable Law, to purchase the Restricted Stock or the shares of Stock subject to such
              vested Stock Units from the Company at a Purchase Price equal to the greater of (i) the aggregate par value of the shares of Stock represented by such Restricted Stock or vested Stock Units or (ii) the Purchase Price, if any, specified in the
              Award Agreement relating to such Restricted Stock or such vested Stock Units. The Purchase Price shall be payable in a form described in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 12
            </font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">or, in the discretion of the Committee, in consideration for past or future Service.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 18 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">10.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Delivery of Stock</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Upon the expiration or termination of any restricted period and the satisfaction of any other conditions prescribed by the
          Committee, including, without limitation, any performance goals or delayed delivery period, the restrictions applicable to shares of Restricted Stock or Stock Units settled in shares of Stock shall lapse, and, unless otherwise provided in the
          applicable Award Agreement, a book-entry or direct registration (including transaction advices) or a stock certificate evidencing ownership of such shares shall, consistent with <font style="font-family: 'Times New Roman'; font-weight: bold;">Section





            3.7</font>, be delivered, free of all such restrictions, to the Grantee or the Grantee&#8217;s beneficiary or estate, as the case may be. Neither the Grantee, nor the Grantee&#8217;s beneficiary or estate, shall have any further rights with regard to
          Restricted Stock or a Stock Unit once the shares of Stock represented by such grant have been delivered in accordance with this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 10.8</font>.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zac7075ec80a548148ca264e5e2fe901a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">TERMS AND CONDITIONS OF UNRESTRICTED STOCK AWARDS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Committee may, in its sole discretion, grant (or sell at par value or such other higher purchase price determined by the
          Committee) an Unrestricted Stock Award to any Grantee pursuant to which such Grantee may receive shares of Stock free of any restrictions (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Unrestricted Stock</font>&#8221;) under the
          Plan. An Award of Unrestricted Stock may be granted or sold as described in the preceding sentence in respect of past or future Service and other valid consideration, or in lieu of, or in addition to, any cash compensation due to such Grantee.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zd202e5d7a7e7485dbfd683e24296695f" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 36pt;">
                <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">12.</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;">FORMS OF PAYMENT</font></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">12.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">General Rule</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payment of the Option Price for the shares purchased pursuant to the exercise of an Option or the Purchase Price, if any, for
          Restricted Stock or vested Stock Units shall be made in cash or in cash equivalents acceptable to the Company.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">12.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Surrender of Shares of Stock</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Unless otherwise stated in the Award Agreement, payment of the Option Price for shares purchased pursuant to the exercise of
          an Option or the Purchase Price, if any, for Restricted Stock or vested Stock Units may be made all or in part through the tender to the Company of shares of Stock, which shall be valued, for purposes of determining the extent to which the Option
          Price or Purchase Price has been paid thereby, at their Fair Market Value on the date of such tender or attestation.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">12.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Cashless Exercise</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">With respect to an Option only (and not with respect to Restricted Stock or vested Stock Units), to the extent permitted by
          Applicable Law and unless otherwise stated in the Award Agreement, payment of the Option Price for shares purchased pursuant to the exercise of an Option may be made all or in part by delivery (on a form acceptable to the Committee) of an
          irrevocable direction to a licensed securities broker acceptable to the Company to sell shares of Stock and to deliver all or part of the sales proceeds to the Company in payment of the Option Price and/or any withholding taxes described in <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 18.3</font>.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 19 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">12.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Other Forms of Payment</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">To the extent the applicable Award Agreement so provides,
            payment of the Option Price for shares purchased pursuant to exercise of an Option or the Purchase Price, if any, for Restricted Stock or vested Stock Units may be made in any other form that is consistent with Applicable Law, including </font><font style="font-size: 10pt;">with the consent of the Committee, by withholding the number of shares of Stock that would otherwise vest or be issuable in an amount equal in value to the Option Price or Purchase Price <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">and/or any withholding taxes described in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 18.3</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z081012520a044e89a4a68b9be21cfff2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">TERMS AND CONDITIONS OF DIVIDEND EQUIVALENT RIGHTS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">13.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Dividend Equivalent Rights</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">A Dividend Equivalent Right may be granted hereunder to any
            Grantee,</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">provided that no Dividend Equivalent Rights may be granted in connection with, or related to, an Award of Options or SARs. The
              terms and conditions of Dividend Equivalent Rights shall be specified in the related </font>Award Agreement<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Dividend equivalents credited to the holder of a Dividend
              Equivalent Right may be paid currently or may be deemed to be reinvested in additional shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment shall be at Fair Market Value on the date of reinvestment.
              Dividend Equivalent Rights may be settled in cash or Stock or a combination thereof, in a single installment or installments, all determined in the sole discretion of the Committee. A Dividend Equivalent Right granted as a component of
              another Award may provide (a) that such Dividend Equivalent Right shall be settled upon exercise, settlement, or payment of, or lapse of restrictions on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited
              or annulled under the same conditions as such other Award or (b) contain terms and conditions different from the terms and conditions of such other award, provided that notwithstanding the foregoing, Dividend Equivalent Rights granted as a
              component of another Award shall not vest or become payable unless and until the Award to which the Dividend Equivalent Rights correspond becomes vested and settled.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">13.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Termination of Service</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Unless the Committee otherwise provides in an Award Agreement or in writing after the Award Agreement is issued, a Grantee&#8217;s
          rights in all Dividend Equivalent Rights shall automatically terminate upon the Grantee&#8217;s termination of Service for any other reason.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z05edf97a593049cda3aeec0b757dd3ff" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">TERMS AND CONDITIONS OF PERFORMANCE AWARDS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">14.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Grant of Performance Awards</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Subject to the terms and provisions of this Plan, the Committee, at any time and from time to time, may grant Performance
          Awards to Grantees in such amounts and upon such terms as the Committee shall determine.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 20 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">14.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Value of Performance Awards</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each grant of a Performance Award shall have an initial cash value or an actual or target number of shares of Stock that is
          established by the Committee as of the Grant Date. The Committee shall set performance goals in its discretion which, depending on the extent to which they are met, will determine the value and/or number of shares of Stock subject to a
          Performance Award that will be earned or paid out to the Grantee thereof.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">14.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Form and Timing of Payment of Performance Awards.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Payment of the value and/or shares of Stock earned with
            respect to a Performance Award shall be as determined by the Committee and as evidenced in the Award Agreement. Subject to the terms of this Plan, the Committee, in its sole discretion, (a) </font><font style="font-size: 10pt;">may pay the
            value earned under a Performance Award in the form of cash, shares of Stock, other Awards, or a combination thereof, including shares of Stock and/or Awards that are subject to any restrictions deemed appropriate by the Committee, and (ii)
            shall pay the value earned under a Performance Award at the close of the applicable performance period, or as soon as reasonably practicable after the Committee has determined that the performance goal or goals relating thereto have been
            achieved; provided that, unless specifically provided in the Award Agreement for such Performance Awards, such payment shall occur no later than the fifteenth (15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day of the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>) month following the end of the
            calendar year in which such Performance Period ends<font style="font-family: 'Times New Roman';">.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">14.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Evaluation of Performance</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything to the contrary in an Award Agreement, any evaluation of performance may include or exclude any of
          the following events that occur during a performance period: (a) asset write-downs; (b) litigation or claim judgments or settlements; (c) the effect of changes in tax laws, accounting principles, or other laws or provisions affecting reported
          results; (d) any reorganization and restructuring programs; (e) extraordinary non-core, non-operating, or nonrecurring items that are either of an unusual nature or of a type that indicates infrequency of occurrence as a separate component of
          income from continuing operations; (f) acquisitions or divestitures activity and related expenses; (g) foreign exchange gains and losses; (h) impact of shares of Stock purchased through share repurchase programs; (i) tax valuation allowance
          reversals; (j) impairment expense; and (k) environmental expense.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 21 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf9463ab23a8f47f8b1e70fb6cc239d75" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">PARACHUTE LIMITATIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding any other provision of this Plan or of any other agreement, contract, or understanding heretofore or
          hereafter entered into by a Grantee with the Company or any Affiliate, except an agreement, contract, or understanding that expressly addresses Section 280G or Section 4999 of the Code (an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Other Agreement</font>&#8221;), and notwithstanding any formal or informal plan or other arrangement for the direct or indirect provision of compensation to the Grantee (including groups or classes of Grantees or beneficiaries of
          which the Grantee is a member), whether or not such compensation is deferred, is in cash, or is in the form of a benefit to or for the Grantee (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Benefit Arrangement</font>&#8221;), if
          the Grantee is a &#8220;disqualified individual,&#8221; as defined in Section 280G(c) of the Code, any Award held by that Grantee and any right to receive any payment or other benefit under this Plan shall be reduced or eliminated (i) to the extent that such
          right to exercise, vesting, payment, or benefit, taking into account all other rights, payments, or benefits to or for the Grantee under this Plan, all Other Agreements, and all Benefit Arrangements, would cause any payment or benefit to the
          Grantee under this Plan to be considered a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code as then in effect (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Parachute Payment</font>&#8221;) and (ii) if, as
          a result of receiving a Parachute Payment, the aggregate after-tax amounts received by the Grantee from the Company under this Plan, all Other Agreements, and all Benefit Arrangements would be less than the maximum after-tax amount that could be
          received by the Grantee without causing any such payment or benefit to be considered a Parachute Payment. Except as required by Code Section 409A or to the extent that Code Section 409A permits discretion, the Committee shall have the right, in
          the Committee&#8217;s sole discretion, to designate those rights, payments, or benefits under this Plan, any Other Agreements, and any Benefit Arrangements that should be reduced or eliminated so as to avoid having the payment or benefit to the Grantee
          under this Plan be deemed to be a Parachute Payment; provided, however, to the extent any payment or benefit constitutes deferred compensation under Code Section 409A, in order to comply with Code Section 409A, the Company shall instead
          accomplish such reduction by first reducing or eliminating any cash payments (with the payments to be made furthest in the future being reduced first), then by reducing or eliminating any accelerated vesting of Performance Awards, then by
          reducing or eliminating any accelerated vesting of Options or SARs, then by reducing or eliminating any accelerated vesting of Restricted Stock or Stock Units, then by reducing or eliminating any other remaining Parachute Payments.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z48d90b614c9943a2864f0f323e28a6f7" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 36pt;">
                <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">16.</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;">REQUIREMENTS OF LAW</font></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">16.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">General</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company shall not be required to sell or issue any shares of Stock under any Award if the sale or issuance of such shares
          would constitute a violation by the Grantee, any other individual exercising an Option or SAR, or the Company of any provision of any Applicable Law, including without limitation any federal or state securities laws or regulations. If at any time
          the Company shall determine, in its discretion, that the listing, registration or qualification of any shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a condition of,
          or in connection with, the issuance or purchase of shares hereunder, no shares of Stock may be issued or sold to the Grantee or any other individual exercising an Option or SAR pursuant to such Award unless such listing, registration,
          qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination of the Award. Without limiting the
          generality of the foregoing, in connection with the Securities Act, upon the exercise of any Option or any SAR that may be settled in shares of Stock or the delivery of any shares of Stock underlying an Award, unless a registration statement
          under such Act is in effect with respect to the shares of Stock covered by such Award, the Company shall not be required to sell or issue such shares unless the Board has received evidence satisfactory to it that the Grantee or any other
          individual exercising an Option may acquire such shares pursuant to an exemption from registration under the Securities Act. Any determination in this connection by the Committee shall be final, binding, and conclusive. The Company may, but shall
          in no event be obligated to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative action in order to cause the exercise of an Option or a SAR or the issuance of shares
          of Stock pursuant to the Plan to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option (or SAR that may be settled in shares of Stock) shall not be
          exercisable until the shares of Stock covered by such Option (or SAR) are registered or are exempt from registration, the exercise of such Option (or SAR) under circumstances in which the laws of such jurisdiction apply shall be deemed
          conditioned upon the effectiveness of such registration or the availability of such an exemption.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 22 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">16.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Rule 16b-3</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During any time when the Company has a class of equity security registered under Section 12 of the Exchange Act, it is the
          intent of the Company that Awards pursuant to the Plan and the exercise of Options and SARs granted hereunder will qualify for the exemption provided by Rule 16b-3 under the Exchange Act. To the extent that any provision of the Plan or action by
          the Board does not comply with the requirements of Rule 16b-3, it shall be deemed inoperative to the extent permitted by Applicable Law and deemed advisable by the Board, and shall not affect the validity of the Plan. In the event that Rule 16b-3
          is revised or replaced, the Board may exercise its discretion to modify this Plan in any respect necessary to satisfy the requirements of, or to take advantage of any features of, the revised exemption or its replacement.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9d64473cb46e4b86a5180142563af7d2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">17.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">EFFECT OF CHANGES IN CAPITALIZATION</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">17.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Changes in Stock</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If the number of outstanding shares of Stock is increased or
            decreased or the shares of Stock are changed into or exchanged for a different number or kind of shares or other securities of the Company on account of any recapitalization, reclassification, stock split, reverse split, combination of shares,
            exchange of shares, stock dividend or other distribution payable in capital stock, or other increase or decrease in such shares effected without receipt of consideration by the Company occurring after the Effective Date, the number and kinds of
            shares for which grants of Options and other Awards may be made under the Plan</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">including the Share Limit set forth in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 4.1</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> and the Non-Employee Director limitation set forth in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 6.3</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, shall be adjusted proportionately and accordingly by the Committee. In
              addition, the number and kind of shares for which Awards are outstanding shall be adjusted proportionately and accordingly so that the proportionate interest of the Grantee immediately following such event shall, to the extent practicable, be
              the same as immediately before such event. Any such adjustment in outstanding Options or SARs shall not change the aggregate Option Price or SAR Exercise Price payable with respect to shares that are subject to the unexercised portion of an
              outstanding Option or SAR, as applicable, but shall include a corresponding proportionate adjustment in the Option Price or SAR Exercise Price per share. The conversion of any convertible securities of the Company shall not be treated as an
              increase in shares effected without receipt of consideration. Notwithstanding the foregoing, in the event of any distribution to the Company&#8217;s stockholders of securities of any other entity or other assets (including an extraordinary dividend
              but excluding a non-extraordinary dividend of the Company) without receipt of consideration by the Company, the Company shall, in such manner as the Company deems appropriate, adjust (i) the number and kind of shares subject to outstanding
              Awards and/or (ii) the Option Price or SAR Exercise Price, as applicable, of outstanding Options and Stock Appreciation Rights to reflect such distribution.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 23 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">17.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Reorganization in Which the Company Is the Surviving Entity Which does not Constitute a Corporate Transaction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Subject to </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 17.3</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> hereof, if the Company shall be the surviving entity in any reorganization,
            merger, or consolidation of the Company with one or more other entities which does not constitute a Corporate Transaction, any Award theretofore granted pursuant to the Plan shall pertain to and apply to the securities to which a holder of the
            number of shares of Stock subject to such Award would have been entitled immediately following such reorganization, merger, or consolidation, with a corresponding proportionate adjustment of the Option Price or SAR Exercise Price per share of
            any outstanding Option or SAR so that the aggregate Option Price or SAR Exercise Price thereafter shall be the same as the aggregate Option Price or SAR Exercise Price of the shares remaining subject to the Option or SAR immediately prior to
            such reorganization, merger, or consolidation. Subject to any contrary language in an Award Agreement evidencing an Award,</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">in another
              agreement with the Grantee, or as otherwise set forth in writing, any restrictions applicable to such Award shall apply as well to any replacement shares received by the Grantee as a result of the reorganization, merger, or consolidation. In
              the event of any reorganization, merger, or consolidation of the Company referred to in this </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Section 17.2</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, Performance Awards shall be adjusted (including any adjustment to the performance goals and/or performance measures applicable to such Awards deemed appropriate by the Committee) so as to apply to the
              securities to which a holder of the number of shares of Stock subject to the Performance Awards would have been entitled to receive immediately following such reorganization, merger, or consolidation.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">17.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Corporate Transaction in which Awards are not Assumed.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Except as otherwise provided in the applicable Award Agreement, in another agreement with the Grantee, or as otherwise set
          forth in writing, upon the occurrence of a Corporate Transaction in which outstanding Awards are not being assumed, continued, or substituted for, the following provisions shall apply to such Award, to the extent not assumed, continued, or
          substituted for:</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Immediately prior to the occurrence of such Corporate Transaction, in each case with the exception of Performance Awards, all outstanding shares of Restricted Stock and all Stock Units and Dividend Equivalent Rights shall be deemed to
              have vested, and the shares of Stock (and/or cash) subject thereto shall be delivered, and either or both of the following two actions shall be taken:</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">At least fifteen days prior to the scheduled consummation of a Corporate Transaction, all Options and SARs outstanding hereunder shall become immediately exercisable and shall remain exercisable for a period of
              fifteen days. Any exercise of an Option or SAR during this fifteen (15)-day period shall be conditioned upon the consummation of the applicable Corporate Transaction and shall be effective only immediately before the consummation thereof, and
              upon consummation of such Corporate Transaction, the Plan and all outstanding but unexercised Options and SARs shall terminate, with or without consideration (including, without limitation, consideration in accordance with clause (ii) below).
              The Committee shall send notice of an event that shall result in such a termination to all Persons who hold Options and SARs not later than the time at which the Company gives notice thereof to its stockholders.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="font-size: 10pt; text-indent: 72pt;"> and/or</div>
        <div style="font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 24 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">To cancel any outstanding Awards of Options, SARs, Restricted Stock, Stock Units, and/or Dividend Equivalent Rights and pay or deliver, or cause to be paid or delivered, to the holder thereof an amount in cash or
              securities having a value (as determined by the Committee acting in good faith), in the case of Restricted Stock, Stock Units, and Dividend Equivalent Rights (if settled in shares of Stock), equal to the formula or fixed price per share paid
              to holders of shares of Stock and, in the case of Options or SARs, equal to the product of the number of shares of Stock subject to the Option or SAR multiplied by the amount, if any, by which (I) the formula or fixed price per share paid to
              holders of shares of Stock pursuant to such transaction exceeds (II) the Option Price or SAR Exercise Price applicable to such Options or SARs.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">For Performance Awards, if less than half of the Performance Period has lapsed, such Performance Awards shall be treated as though target performance has been achieved. If at least half of the Performance Period has lapsed, actual
              performance to date shall be determined as of a date reasonably proximal to the date of consummation of the Corporate Transaction as determined by the Committee, in its sole discretion, and that level of performance thus determined shall be
              treated as achieved immediately prior to occurrence of the Corporate Transaction. For purposes of the preceding sentence, if, based on the discretion of the Committee, actual performance is not determinable, the Performance Awards shall be
              treated as though target performance has been achieved. After application of this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17.3(b)</font>, if any Awards arise from application of this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17.3(b)</font>, such Awards shall be settled under the applicable provision of <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17.3(a)</font>.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">17.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Corporate Transaction in which Awards are Assumed.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Except as otherwise provided in the applicable Award Agreement, in another agreement with the Grantee, or as otherwise set
          forth in writing, upon the occurrence of a Corporate Transaction in which outstanding Awards are being assumed, continued, or substituted for, the following provisions shall apply to such Award, to the extent assumed, continued, or substituted
          for:</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Plan and the Options, SARs, Restricted Stock, Stock Units and Dividend Equivalent Rights granted under the Plan shall continue in the manner and under the terms so provided in
                the event of any Corporate Transaction to the extent that provision is made in writing in connection with such Corporate Transaction for the assumption or continuation of such Options, SARs, Restricted Stock, Stock Units, and Dividend
                Equivalent Rights, or for the substitution for such Options, SARs, Restricted Stock, Stock Units, and Dividend Equivalent Rights of new stock options, stock appreciation rights, restricted stock, restricted stock units, and/or dividend
                equivalent rights relating to the securities of a successor entity, or a parent or subsidiary thereof, with appropriate adjustments as to the number of shares (disregarding any consideration that is not common stock) and exercise prices of
                options and stock appreciation rights.</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 255);"><u>&#160;</u></font><font style="font-family: 'Times New Roman';">Performance Awards shall not be assumed pursuant to this </font><font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17.4</font><font style="font-family: 'Times New Roman';">, but shall instead be settled in accordance with </font><font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17.3(b)</font><font style="font-family: 'Times New Roman';"> hereof.</font></font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 25 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In the event a Grantee&#8217;s Award is assumed, continued or substituted upon the consummation of any Corporate Transaction and the Grantee&#8217;s employment is terminated without Cause within one year following the consummation of such
              Corporate Transaction, the Grantee&#8217;s Award will be fully vested and may be exercised in full, to the extent applicable, beginning on the date of such termination and for the one-year period immediately following such termination or for such
              longer period as the Committee shall determine (subject to any earlier expiration of the term of such assumed options or stock appreciation rights).</font></font></div>
        <div style="font-size: 10pt;"><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">17.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Adjustments</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Adjustments under this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17</font> related to shares
          of Stock or securities of the Company shall be made by the Committee, whose determination in that respect shall be final, binding, and conclusive. No fractional shares or other securities shall be issued pursuant to any such adjustment, and any
          fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the nearest whole share. The Committee may provide in the Award Agreements at the time of grant, or any time thereafter with, if necessary, the
          consent of the Grantee, for different provisions to apply to an Award in place of those described in <font style="font-family: 'Times New Roman'; font-weight: bold;">Sections 17.1, 17.2</font>, <font style="font-family: 'Times New Roman'; font-weight: bold;">17.3 </font>and<font style="font-family: 'Times New Roman'; font-weight: bold;"> 17.4</font>. This <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 17</font> shall not limit the Committee&#8217;s ability
          to provide for alternative treatment of Awards outstanding under the Plan in the event of a change in control event involving the Company that is not a Corporate Transaction.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">17.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">No Limitations on Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The making of Awards pursuant to the Plan shall not affect or limit in any way the right or power of the Company to make
          adjustments, reclassifications, reorganizations, or changes of its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part of its business or assets.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1e1ec371fc3349a48a53b1163136a856" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">GENERAL PROVISIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Disclaimer of Rights.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">No provision in the Plan or in any Award or Award Agreement shall be construed to confer upon any individual the right to
          remain in the employ or service of the Company or any Affiliate, or to interfere in any way with any contractual or other right or authority of the Company either to increase or decrease the compensation or other payments to any individual at any
          time, or to terminate any employment or other relationship between any individual and the Company. In addition, notwithstanding anything contained in the Plan to the contrary, unless otherwise stated in the applicable Award Agreement, no Award
          granted under the Plan shall be affected by any change of duties or position of the Grantee, so long as such Grantee continues to be a director, officer, consultant or employee of the Company or an Affiliate. The obligation of the Company to pay
          any benefits pursuant to this Plan shall be interpreted as a contractual obligation to pay only those amounts described herein, in the manner and under the conditions prescribed herein. The Plan shall in no way be interpreted to require the
          Company to transfer any amounts to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee or beneficiary under the terms of the Plan.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 26 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Nonexclusivity of the Plan.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Neither the adoption of the Plan nor the submission of the Plan to the stockholders of the Company for approval shall be
          construed as creating any limitations upon the right and authority of the Board to adopt such other incentive compensation arrangements (which arrangements may be applicable either generally to a class or classes of individuals or specifically to
          a particular individual or particular individuals) as the Board in its discretion determines desirable, including, without limitation, the granting of stock options otherwise than under the Plan.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Withholding Taxes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company or an Affiliate, as the case may be, shall have the right to deduct from payments of any kind otherwise due to a Grantee any federal, state, or local taxes of any kind required by Applicable Law to be withheld with respect
              to the vesting of or other lapse of restrictions applicable to an Award or upon the issuance of any shares of Stock upon the exercise of an Option or pursuant to an Award. At the time of such vesting, lapse, or exercise, the Grantee shall pay
              in cash to the Company or the Affiliate, as the case may be, any amount that the Company or the Affiliate may reasonably determine to be necessary to satisfy such withholding obligation. Subject to the prior approval of the Committee, which
              may be withheld by the Committee, in its sole discretion, the Grantee may elect to satisfy such obligations, in whole or in part, (i) by causing the Company or the Affiliate to withhold shares of Stock otherwise issuable to the Grantee or
              (ii) by delivering to the Company or the Affiliate shares of Stock already owned by the Grantee. The shares of Stock so delivered or withheld shall have an aggregate Fair Market Value equal to such withholding obligations. The Fair Market
              Value of the shares of Stock used to satisfy such withholding obligation shall be determined by the Company or the Affiliate as of the date that the amount of tax to be withheld is to be determined. A Grantee who has made an election pursuant
              to this <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 18.3</font> may satisfy his or her withholding obligation only with shares of Stock that are not subject to any repurchase, forfeiture, unfulfilled vesting, or
              other similar requirements.</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The maximum number of shares of Stock that may be withheld from any Award to satisfy any federal, state or local tax withholding requirements upon the exercise, vesting, lapse of restrictions applicable to such Award or payment of
              shares pursuant to such Award, as applicable, cannot exceed such number of shares having a Fair Market Value equal to the minimum statutory amount required by the Company to be withheld and paid to any such federal, state or local taxing
              authority with respect to such exercise, vesting, lapse of restrictions or payment of shares; provided, however, for so long as Accounting Standards Update 2016-09 or a similar rule remains in effect, the Board or the Committee has full
              discretion to choose, or to allow a Grantee to elect, to withhold a number of shares of Stock having an aggregate Fair Market Value that is greater than the applicable minimum required statutory withholding obligation (but such withholding
              may in no event be in excess of the maximum required statutory withholding amount(s) in such Grantee&#8217;s relevant tax jurisdictions).</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 27 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Captions</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The use of captions in this Plan or any Award Agreement is for the convenience of reference only and shall not affect the
          meaning of any provision of the Plan or such Award Agreement.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Other Provisions.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each Award granted under the Plan may contain such other terms and conditions not inconsistent with the Plan as may be
          determined by the Committee, in its sole discretion.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Number and Gender.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">With respect to words used in this Plan, the singular form shall include the plural form, the masculine gender shall include
          the feminine gender, etc., as the context requires.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Severability</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in
          any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Governing Law.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The validity and construction of this Plan and the instruments evidencing the Awards hereunder shall be governed by the laws
          of the State of Delaware, other than any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan and the instruments evidencing the Awards granted hereunder to the substantive laws of
          any other jurisdiction.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">18.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 409A of the Code.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Plan is intended to comply with Code Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan
          will be interpreted and administered to be in compliance with Code Section 409A. Notwithstanding any provision of the Plan or any Award Agreement to the contrary, to the extent required to avoid accelerated taxation and tax penalties under Code
          Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6)-month period immediately following the Grantee&#8217;s &#8220;separation from service&#8221; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(as defined for purposes of Code Section 409A)</font> will instead be paid on the first payroll date after the six (6)-month anniversary of the Grantee&#8217;s separation from service (or the Grantee&#8217;s death,
          if earlier). <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding anything in the Plan or any Award Agreement to the contrary, in the case of an Award that is characterized as deferred compensation under Code
            Section 409A, and pursuant to which settlement and delivery of the cash or shares of Stock subject to the Award is triggered based on a Corporate Transaction, in no event will a Corporate Transaction be deemed to have occurred for purposes of
            such settlement and delivery of cash or shares of Stock if the transaction is not also a &#8220;change in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial portion of the assets of&#8221; the Company as
            determined under Treasury Regulation Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder). If an Award characterized as deferred compensation under Code Section 409A is not settled and delivered on account of the
            provision of the preceding sentence, the settlement and delivery shall occur on the next succeeding settlement and delivery triggering event that is a permissible triggering event under Code Section 409A. No provision of this paragraph shall in
            any way affect the determination of a Corporate Transaction for purposes of vesting in an Award that is characterized as deferred compensation under Code Section 409A. </font>Notwithstanding the foregoing, neither the Company nor the Committee
          will have any obligation to take any action to prevent the assessment of any excise tax or penalty on any Grantee under Code Section 409A, and neither the Company or an Affiliate nor the Board or the Committee will have any liability to any
          Grantee for such tax or penalty<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*&#160; &#160; *&#160; &#160; *</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 28 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">To record adoption of the Plan by the Board as of March 18, 2024 and approval of the Plan by the Company&#8217;s stockholders as of May 21, 2024, the
        Company has caused its authorized officer to execute the Plan.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z483cda32754949f4911dcfc601bd59b5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">NBT BANCORP INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: middle; font-size: 10pt;">&#160;</td>
            <td style="width: 45%; vertical-align: middle; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman';">By: <font style="font-family: 'Times New Roman';">/s/ <u>Scott A. Kingsley</u></font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Scott A. Kingsley</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">President and Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 29 -</font>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ef20029559_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 10.2</font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NBT BANCORP INC.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2024 OMNIBUS INCENTIVE PLAN</div>
        <div>&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">LONG-TERM INCENTIVE PROGRAM</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESTRICTED STOCK UNIT AWARD AGREEMENT</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(TRSU AND PRSU)</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cover Sheet</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">NBT Bancorp Inc., a Delaware corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Company</font>&#8221;), hereby grants time-based vesting Stock Units (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">TRSUs</font>&#8221;) and performance-based vesting Stock Units (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">PRSUs</font>&#8221; and together with the TRSUs, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Award Units</font>&#8221;) relating to shares of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Stock</font>&#8221;), to the
          individual named below as the Grantee, subject to the terms and conditions set forth in this cover sheet, in the attached Restricted Stock Unit Award Agreement (together with this cover sheet, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Agreement</font>&#8221;), and in the Company&#8217;s 2024 Omnibus Incentive Plan (as it has been or may be amended and/or restated from time to time, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Plan</font>&#8221;). Certain capitalized terms used in the Agreement are defined in the Plan and have the meaning set forth in the Plan.</div>
        <div>&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name of Grantee:</div>
        <div><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Grant Date:</div>
        <div><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Number of Shares of Stock covered by the TRSUs:</div>
        <div><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Number of Shares of Stock covered by the Target Award of PRSUs:</div>
        <div><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Performance Period:</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-indent: 36pt;">By acknowledging this agreement online, you are authorizing your electronic signature and certifying that
          you agree to all of the terms and conditions described in the Agreement and in the Plan, an electronic copy of which has been made available to you. You acknowledge that you have carefully reviewed the Plan and agree that the Plan will control in
          the event any provision of this Agreement should appear to be inconsistent. You must accept your grant no later than 5 pm Eastern Time, five (5) business days prior to the first vesting date or your entire grant will be cancelled.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="z5255836bf5f247028a6b4f1bd1c9a988">

            <tr>
              <td style="width: 10%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Company:</div>
              </td>
              <td style="width: 90%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>/s/ Scott A. Kingsley</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 10%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
              </td>
              <td style="width: 90%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Scott A. Kingsley</div>
              </td>
            </tr>
            <tr>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Title:</div>
              </td>
              <td style="width: 90%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">President and Chief Executive Officer</div>
              </td>
            </tr>

        </table>
        <div style="clear: both;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">This is not a stock certificate or a negotiable instrument.</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;NBT BANCORP INC.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2024 OMNIBUS INCENTIVE PLAN</div>
        <div style="text-align: center;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">LONG-TERM INCENTIVE PROGRAM</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESTRICTED STOCK UNIT AWARD AGREEMENT</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(TRSU AND PRSU)</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z321765ab10834985a46b76cc04013d7d">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TRSUs and PRSUs</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement evidences a grant of time-based vesting Stock Units, subject to the vesting and achievement conditions described below (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">TRSUs</font>&#8221;) and a grant of performance-based vesting Stock Units, subject to the vesting, achievement, and performance conditions
                  described below (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">PRSUs</font>&#8221;). The TRSUs and PRSUs are referred to together as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Award Units</font>.&#8221;</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Transferability</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Your Award Units may not be sold, transferred, assigned, pledged, hypothecated, or otherwise encumbered, whether by operation of law or otherwise, nor may
                  the Award Units be made subject to execution, attachment, or similar process. If you attempt to do any of these things, you will immediately and automatically forfeit your Award Units.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number and </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Vesting of TRSUs</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The TRSUs are subject to the time-based vesting conditions and will vest in accordance with the vesting schedule set forth on <u><font style="font-size: 10pt; font-family: 'Times New Roman';">Exhibit A</font></u> to this Agreement, so long as you continue in Service on each applicable vesting date.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">No TRSUs shall vest after your Service has terminated for any reason.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">You will immediately and automatically forfeit to the Company (i) all of your unvested TRSUs in the event your Service terminates for any reason, unless the
                  termination of your Service triggers accelerated vesting or other treatment of your unvested TRSUs pursuant to the terms of this Agreement, the Plan, a written employment or other written compensatory agreement between you and the Company
                  or an Affiliate, or a written compensatory program or policy of the Company or an Affiliate otherwise applicable to you; or (ii) all of your unvested TRSUs and any shares of Stock previously received as a result of the vesting of TRSUs in
                  the event the Company determines, in the exercise of good faith, that you are or have been non-compliant with any restrictive covenants by which you are bound, including any confidentiality, non-competition, or non-solicitation covenant
                  set forth in an employment agreement or other contractual instrument.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number and </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Vesting of PRSUs</div>
                <div>&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The PRSUs are subject to a combination of time-based vesting and performance-based vesting conditions set forth on <u><font style="font-size: 10pt; font-family: 'Times New Roman';">Exhibit B</font></u> to this Agreement. Promptly following the end of the Performance Period (and no later than ninety (90) days following the end of the Performance Period), as set forth on the cover
                  sheet of this Agreement, the Committee will determine and certify the level of achievement of the Performance Factors set forth on <u><font style="font-size: 10pt; font-family: 'Times New Roman';">Exhibit B</font></u> (such date of
                  determination, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Certification Date</font>&#8221;) and will determine the number of Earned PRSUs (as defined in <u><font style="font-size: 10pt; font-family: 'Times New Roman';">Exhibit B</font></u>) based on such achievement. Such certification and determination will be final, conclusive, and binding. Except as otherwise set forth in this Agreement, your Earned PRSUs
                  will vest as of the Certification Date, so long as you continue in Service on the Certification Date.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">You will immediately and automatically forfeit to the Company all of your PRSUs in the event (i) your Service terminates for any reason prior to the
                  Certification Date, except as otherwise provided in this Agreement; (ii) the Company determines in the exercise of good faith that you are or have been non-compliant with any restrictive covenants by which you are bound, including any
                  confidentiality, non-competition, or non-solicitation covenant set forth in an employment agreement or other contractual instrument; or (iii) such PRSUs do not become Earned PRSUs following the Performance Period.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Delivery of Stock </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Vested </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Award Units</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Your vested Award Units will not be settled in cash. Except as specified below, shares of Stock underlying the vested Award Units will be delivered to you by
                  the Company as soon as practicable following the applicable vesting date but in no event later than thirty (30) days following such vesting date; provided that (i) if such vesting date occurs during a period in which you are (A) subject
                  to a lock-up agreement restricting your ability to sell Stock in the open market or (B) are restricted from selling Stock in the open market because a trading window is not available, and (ii) the Company elects not to satisfy its tax
                  withholding obligations by withholding shares of Stock from the shares otherwise deliverable, withholding from other compensation otherwise payable to you by the Company or its Affiliates, or by permitting you to pay your withholding
                  taxes in cash, then delivery of the vested shares will be delayed until the date immediately following the expiration of the lock-up agreement or the opening of a trading window but in no event beyond the last day of the calendar year in
                  which such distribution would otherwise have been made.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything to the contrary in this Agreement, delivery of the shares of Stock represented by your vested Award Units will be made in accordance
                  with your deferral election attached as <u><font style="font-size: 10pt; font-family: 'Times New Roman';">Exhibit C</font></u> to this Agreement, if applicable.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The issuance of the shares of Stock represented by your vested Award Units shall be evidenced in such a manner as the Company, in its discretion, deems
                  appropriate, including, without limitation, by (i) book-entry registration or (ii) issuance of one or more share certificates.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Vesting and </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Delivery upon </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Termination of </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Employment for </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TRSUs</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Death/Disability/Retirement/Termination without Cause or for Good Reason</font>.<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</font>If your Service terminates because of your death, Disability, Retirement (as defined below), your involuntary termination of Service by the Company
                  without Cause or your voluntary termination of Service for Good Reason (as defined below), then 100% of your then-unvested TRSUs will vest on the effective date of your termination of Service, at the discretion of the Compensation and
                  Benefits Committee. Shares underlying the vested TRSUs will be delivered on the delivery date specified under the &#8220;Delivery of Stock Pursuant to Vested Award Units&#8221; heading above.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Other Termination of Service</font>. If you incur a termination of Service
                  for any reason other than those specified above, whether voluntary or involuntary and prior to a Corporate Transaction, you will immediately and automatically forfeit your then-unvested TRSUs.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcb828be46b1749568cb2713a5b923ae0">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Vesting and </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Delivery upon </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Termination of </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Employment for </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PRSUs</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Death/Disability</font>. If your Service terminates prior to the end of
                  the Performance Period because of your death or Disability, then 100% of the shares underlying your Target Award of PRSUs will vest on the effective date of your termination of Service, at the discretion of the Compensation and Benefits
                  Committee.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If your Service terminates following the end of the Performance Period but prior to the Certification Date because of your death or Disability, then 100% of
                  the shares underlying your Earned PRSUs will vest as of the Certification Date, at the discretion of the Compensation and Benefits Committee.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In each case of the foregoing, Shares underlying the vested PRSUs or Earned PRSUs as described above will be delivered on the delivery date specified under
                  the &#8220;Delivery of Stock Pursuant to Vested Award Units&#8221; heading above.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Retirement/Termination without Cause or for Good Reason</font>. If your
                  Service terminates prior to the end of the Performance Period because of your Retirement, your involuntary termination of Service by the Company without Cause or your voluntary termination of Service for Good Reason (as defined below),
                  then you will vest on the effective date of your termination of Service with respect to a percentage of the shares underlying your Target Award of PRSUs equal to the number of months (rounded to the nearest whole month) of the Performance
                  Period prior to your termination of Service, divided by 36, at the discretion of the Compensation and Benefits Committee.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If your Service terminates after the end of the Performance Period but prior to the Certification Date because of your Retirement, your involuntary
                  termination of Service by the Company without Cause or your voluntary termination of Service for Good Reason, then 100% of the shares underlying your Earned PRSUs will vest as of the Certification Date, at the discretion of the
                  Compensation and Benefits Committee.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In each case of the foregoing, shares underlying the vested PRSUs or Earned PRSUs as described above will be delivered on the delivery date specified under
                  the &#8220;Delivery of Stock Pursuant to Vested Award Units&#8221; heading above.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For clarity, in the event of a termination specified in the foregoing paragraphs, you are not required to remain in continued Service through the
                  Certification Date to vest in all or a portion of your PRSUs, as described above.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Other Termination of Service</font>. If, before the Certification Date,
                  you incur a termination of Service for any reason other than those specified above, whether voluntary or involuntary and prior to a Corporate Transaction, you will immediately and automatically forfeit your PRSUs.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc07266b75cff4a509c2be26aca215ce0">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Definition of </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retirement and </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Good Reason</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this Agreement, the following definitions will apply:</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; text-indent: -36pt; margin-left: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Retirement</font>&#8221; means before the last Vesting Date with respect to the TRSUs or before the Certification Date with respect to the
                    PRSUs, a voluntary termination of Service on or after the date you reach the age of 55, and provided that (a) you have attained at least 4 years of Service; and (b) you covenant that, without the express written consent of the
                    Compensation and Benefits Committee, you will not engage in any full-time employment with, or provide consulting services to, any entity thereafter (although you will be entitled to engage in part-time employment, or consult, with an
                    entity that does not compete with the Company), unless such employment has been approved by the Compensation and Benefits Committee.</font></div>
                <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
                  </font></div>
                <div style="text-align: justify; text-indent: -36pt; margin-left: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Good Reason</font>&#8221; means the occurrence of either of the following circumstances, without your express written consent: (A) a material
                    diminution in your base salary; or (B) a material diminution in your authority, duties, or responsibilities. Notwithstanding the foregoing, a resignation will not be considered to have been on account of Good Reason unless: (1) you
                    provide the Company not less than 30 days&#8217; advance notice in writing within 90 days of the initial occurrence of the condition that is the basis for such Good Reason and the Company does not correct the condition in the 30-day period;
                    and (2) you resign by no later than 60 days after the Company&#8217;s time period for correcting the condition has expired.</font></div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Corporate </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Transaction</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">TRSUs</font>. In the event of a Corporate Transaction and subject to your
                  continued Service as of immediately prior to the effective time of such Corporate Transaction, then 100% of your then-unvested TRSUs will vest as of immediately prior to the effective time of such Corporate Transaction.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">PRSUs</font>. Subject to Section 17.3 of the Plan, (a) in the event of a
                  Corporate Transaction during the Performance Period (but less than half of the Performance Period has lapsed) and subject to your continued Service as of immediately prior to the effective time of such Corporate Transaction, then 100% of
                  the shares underlying the Target Award of PRSUs will vest as of immediately prior to the effective time of such Corporate Transaction, and (b) in the event of a Corporate Transaction (1) during the Performance Period (but at least half of
                  the Performance Period has lapsed) or (2) following the end of the Performance Period but prior to the Certification Date, then 100% of the shares underlying your Earned PRSUs will vest as of immediately prior to the effective time of
                  such Corporate Transaction.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In each case of the foregoing, shares underlying the vested TRSUs, vested PRSUs or Earned PRSUs as described above will be delivered on the delivery date
                  specified under the &#8220;Delivery of Stock Pursuant to Vested Award Units&#8221; heading above.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z25e298e9bfe9457988b560dd974622de">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Dividend </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equivalent Rights</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each Award Unit is granted with an accompanying Dividend Equivalent Right. Such Dividend Equivalent Right will be paid in cash and will be based on the
                  amount of any cash dividend paid by the Company on the Stock underlying your grant that is paid after the applicable vesting date with respect to your Award Units but prior to the date the shares of Stock underlying such Award Units are
                  delivered to you pursuant to this Agreement. The Dividend Equivalent Right will be calculated as the product of: (a) the number of shares underlying your vested, but-not-yet-delivered Award Unit (measured as of the ex-dividend date for
                  the Stock) times (b) the per share cash dividend amount paid to holders of the Stock. The Company will pay the Dividend Equivalent Rights to you at the time dividends are paid on the Stock.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Your right to receive Dividend Equivalent Rights terminates upon your termination of Service for any reason.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Withholding Taxes</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">You agree, as a condition of this grant, that you will make acceptable arrangements to pay any withholding or other taxes that may be due as a result of
                  vesting in Award Units, payment of Dividend Equivalent Rights, or your acquisition of Stock under this grant. In the event that the Company determines that any federal, state, local or foreign tax or withholding payment is required
                  relating to this grant, the Company will have the right to: (i) require that you arrange such payments to the Company; (ii) withhold such amounts from other payments due to you from the Company or any Affiliate; (iii) permit or require
                  you to enter into a &#8220;same day sale&#8221; commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">FINRA</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Dealer</font>&#8221;), whereby you irrevocably elect to
                  sell a portion of the shares of Stock to be delivered in connection with the Award Units to satisfy withholding obligations and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the withholding
                  obligations directly to the Company or any Affiliate, or (iv) withhold the delivery of vested shares of Stock otherwise deliverable under this Agreement to meet such obligations, provided that, to the extent required to avoid adverse
                  accounting consequences to the Company, the shares of Stock so withheld will have an aggregate Fair Market Value not exceeding the minimum amount of tax required to be withheld by Applicable Laws.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retention Rights</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Neither your grant of Award Units nor this Agreement gives you the right to be retained by the Company (or any Affiliates) in any capacity, nor shall your
                  grant or this Agreement, subject to any employment agreement you may have with the Company or any Affiliates, alter the at-will nature of employment. The Company (and any Affiliate) reserves the right to terminate your Service at any time
                  and for any reason.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stockholder Rights</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Except as set forth above under &#8220;Dividend Equivalent Rights,&#8221; you do not have any of the rights of a stockholder with respect to the Award Units unless and
                  until the Stock relating to the Award Units has been delivered to you.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4fb2064252ac40a1814f1ab01981ddb1">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjustments</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In the event of a stock split, a stock dividend, or a similar change in the Stock, the number of Award Units covered by this grant will be adjusted (and
                  rounded down to the nearest whole number) in accordance with the terms of the Plan.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Applicable Law</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement (including the cover sheet and all exhibits and appendices) will be interpreted and enforced under the laws of the State of Delaware, other
                  than any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Data Privacy</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">To administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to, the information provided in this
                  Agreement and any changes thereto, other appropriate personal and financial data about you, such as home address and business addresses and other contact information, payroll information, and any other information that might be deemed
                  appropriate by the Company to facilitate the administration of the Plan.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By accepting this grant, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to
                  transfer any such personal data outside the country in which you work, including, with respect to non-U.S. resident grantees, to the United States, to transferees who will include the Company and other persons who are designated by the
                  Company to administer the Plan.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Consent to Electronic </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Delivery</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company may choose to deliver certain statutory materials relating to the Plan in electronic form. By accepting this grant, you agree that the Company
                  may deliver the Plan prospectus and the Company&#8217;s annual report to you in an electronic format. If at any time you would prefer to receive paper copies of these documents, as you are entitled to receive, the Company would be pleased to
                  provide copies. Please contact the Secretary of the Company to request paper copies of these documents.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Clawback</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Award Units are subject to repayment by you to the Company in the circumstances specified in the Plan, including to the extent you are or in the future
                  become subject to any Company &#8220;clawback&#8221; or recoupment policy or Applicable Laws that require the repayment by you to the Company of compensation paid by the Company to you in the event that you fail to comply with, or violate, the terms
                  or requirements of such policy or Applicable Laws.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Disclaimer of Rights</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The grant of Award Units under this Agreement will in no way be interpreted to require the Company to transfer any amounts to a third-party trustee or
                  otherwise hold any amounts in trust or escrow for payment to you. You will have no rights under this Agreement or the Plan other than those of a general unsecured creditor of the Company. Award Units represent unfunded and unsecured
                  obligations of the Company, subject to the terms and conditions of the Plan and this Agreement.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3898b8598d3d4eb79ef4bfa9c30afa8f">

            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Code Section 409A</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The grant of Award Units under this Agreement is intended to comply with or to be exempt from Code Section 409A <font style="font-size: 10pt; font-family: 'Times New Roman';">(&#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Section 409A</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;), </font>and this
                  Agreement shall be interpreted and administered accordingly to the maximum extent possible. Notwithstanding anything to the contrary in the Plan or this Agreement, none of the Company, its Affiliates, the Board, or the Committee will have
                  any obligation to take any action to prevent the assessment of any excise tax or penalty on you under Section 409A, and none of the Company, its Affiliates, the Board, or the Committee will have any liability to you for such tax or
                  penalty.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">To the extent that all or a portion of the Award Units constitute &#8220;deferred compensation&#8221; under Section 409A, a termination of Service occurs only upon an
                  event that would be a &#8220;separation from service&#8221; within the meaning of Section 409A. If, at the time of your &#8220;separation from service,&#8221; (i) you are a &#8220;specified employee&#8221; within the meaning of Section 409A, and (ii) the Company makes a
                  good faith determination that an amount payable on account of your &#8220;separation from service&#8221; constitutes deferred compensation (within the meaning of Section 409A), the payment of which is required to be delayed pursuant to the six
                  (6)-month delay rule set forth in Section 409A to avoid taxes or penalties under Section 409A (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Delay Period</font>&#8221;), then the
                  Company will not pay such amount on the otherwise scheduled payment date but will instead pay it in a lump sum on the first business day after the Delay Period (or upon your death, if earlier), without interest.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each installment of Award Units that vest under this Agreement (if there is more than one installment) will be considered one of a series of separate
                  payments for purposes of Section 409A.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 82%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 18%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">The Plan</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The text of the Plan is incorporated in this Agreement by reference. This Agreement (including the cover sheet and all exhibits and appendices) and the Plan
                  constitute the entire understanding between you and the Company regarding this grant of Award Units. Any prior agreements, commitments, or negotiations concerning this grant are superseded.</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
                </div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Certain capitalized terms used in this Agreement are defined in the Plan and have the meaning set forth in the Plan.</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> <br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; margin-left: 18pt;">By acknowledging this Agreement online, you agree to all of the terms and conditions described in this
          Agreement and in the Plan.</div>
        <div>&#160;</div>
        <div> <br>
        </div>
        <div style="text-align: center; font-size: 8pt;">8<br>
        </div>
      </div>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>nbtb-20240521.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<xs:schema targetNamespace="http://nbtbank.com/20240521" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nbtb="http://nbtbank.com/20240521" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="nbtb-20240521_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="nbtb-20240521_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://nbtbank.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>nbtb-20240521_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>nbtb-20240521_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://nbtbank.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="nbtb-20240521.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://nbtbank.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139722583498016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 21, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 21,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-14703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NBT BANCORP INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1268674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">52 South Broad Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Norwich<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">13815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">337-2265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NBTB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M)+=]ASK'$R]BO3'VA#OHI6S-Y]S\GLX4C-Q")10Q3[20"5%\U7>&]&[D-VU
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  S@+58F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M #. M5C9S-]04@0  ) 0   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  S@+58GZ ;\+$"  #B#   #0
M            @ &5#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #. M5B7
MBKL<P    !,"   +              "  7$/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( #. M5@<.&7J/P$  #P"   /              "  5H0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  S@+58)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  S@+5899!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20029559_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nbtbank.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20029559_8k.htm">ef20029559_8k.htm</File>
    <File>nbtb-20240521.xsd</File>
    <File>nbtb-20240521_lab.xml</File>
    <File>nbtb-20240521_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20029559_8k.htm": {
   "nsprefix": "nbtb",
   "nsuri": "http://nbtbank.com/20240521",
   "dts": {
    "inline": {
     "local": [
      "ef20029559_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "nbtb-20240521.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "nbtb-20240521_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nbtb-20240521_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://nbtbank.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240521to20240521",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20029559_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240521to20240521",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20029559_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nbtbank.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-24-027021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-027021-xbrl.zip
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M+J: 9[:<SP.&/A$GSH2X<C]_"/@ W<-EWNO,9KN("9C9X%#AF:);<AN%]\D
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M)#<EB^WM=)H4\ZP'PA%)"1.JTE0)D#U'N1.P;.L[ RSM (7$],IDZ BK V
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M_D%N1B4*/=<[ 0OW<[ W_%X;== +HS]OBWR4Q1O^3_:4Z9$?@T%8W";9!JS
MST$XJG+]54$OH>]Z>1$+^:PLSP2O# U?C<E^-MXIKZJOQ ./O)>G<7U//GPZ
M^WZ7]!))$UN;V[Q.3RSG+[WBDR(K=<??K&5M&2+M^'.)!G9OKH:C7V5>,>XU
M:M.9,(K;WMI6)X#_K3__[4%]1S]\NOCU)OBU>W'R]>HR.+\XV;0G[X^L/IW_
M]1_;!UL?W7N\3_,R46177W^_./_UVS7,].SBYOR/L^#R2_=BW)Q?=Y"!38ZU
MI9S/A;WI_OKE+/CZ.3CY>G$C5_7ZJ5&W<Z#I#.B7T2?@^+_\;?3)>WD5]J1\
MBT2:EL,PDN+O[Q^V/N#G81C'ZC.Q3OPSB?_^X=]'O6AGIQ<=[1V$AWOQT>%1
MN+-W%!W$XGA_>W=KZ^CE(NTAB:L[^+#UD^+8( /2<%C*:]1?$XL^^L>2V7+&
M-CG1-[$:+K]]7[[[7A15$H6I>DF5#QN&6Y=40$X[6WN=8&?W2/YK?W_]XP<8
MFUQ>*06W/WS:E@REBE]_#$7^H,9@QK/SP1O(#_+W#Y\NOUU=?KT^\QD(T?T;
MS'OB^4UVWN3^330U^85+9U.E.Y>B=J9,4:]&*Z=GG\\OSF_.OUY<SYY>EI,2
M7L*!=I>; W5/?Y=4=7USU07* C%\\X]FK6;Z1#;94@1-EL;!F_(0I;:^S8F;
M<&=W-R<[<DVC/GJ[89_D@T%254+43(GI$^#TN=R!JX"K02\DYYL%E4];#YGX
M+.R\PEEXH\G]FH=%_ JGY:UTR,,Y.#\+R?]W%Y'_WXAB4 9Y/^@^2+(N%U(*
MS /%OGN.O[>\'/\B#Z[$L$C !17\,ZGN\E$57%=Y].==GL:B"+K#89'?A^D2
M2X7C.3AC"RD5]A=1*IR*OBB*, VZ\M_9K8!(Y$**AGD@VW<O&@Z66C1\2<)>
MDB;5XXK[K[B_3_J3J:9SQOVO[\)"!.=E.0JS2/SMUSS_<^,LJXK7H/#EI-V7
MB("]Y?:$7]]\/?G/X/K;K__G[.0FN/DZ=X[P&<1DMN: %!>0C>XMIFN=<MC
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MQX>22$J""H6=XF D_],0&$N<1R.L!0O6),M*1\@JL/XQZ-X60N!OZR2(R%Z
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M8&UG72]K)FY3 7XMN5"IW$ 8B[L2A>B/2OE$.:8H+(I'M!GXW3J1@QZ-)R^
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MC7EYH2 '=1T,-I1W;GJJ]EI"A:*\$M0:RLX'SW3XQ,SP2Q80<$UM)/[4D\%
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M;'3!.GDP;)"4HPDE/8IB\E5I(BZ_6(2"D)K@WI7.MOB!OZ:3TQ2J405$'4:
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MEGZ]%_RC;^G W-!XPA M1J1'BHH;&X" <OW >?\X?J7OL%<UY^E8^H^0M):
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MRIO;T&EY0ZRD@6;-O5$I)97<->"VE56G$D@R(?AY')WME%P+'>]G^LC:-.Q
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M4$20(:-Z[.+JJ:O!3@7QGL6Z'27(:]/0S$U5EI-OR6*FW&M5[MLKA8,FBD.
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M\I7_ @JQ.H@(Y3M&[-8Q?:@IAXKR=8RME"9[#VO)+5W;2J7#G#:;\R=%-!I
MUE#$8D&5E>-#&!&!<?ZD;$@:X.(TN*'.!WNQK8!->+B4S6^P27-YCKINU9L^
MH; W*>=3T<@9U,R1Q!H3P-W-/CS"VLFD<F)]S6DH_5$!NZ.6H.]3B%'1L:*0
M(20X/A<J 978B//6BD%4TF;Q00JX8Z.AU6$8^+A4_C6*-=]MT NXG ^Q+])Z
MTS'>M7PH,HU_7V!X4CW9!>K"I8$GH3WY],.D*A2.N*[1FAD"%T+47JA:"S5
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MQX"OO%N_"TQ(QMQLU+@I/WL6Z=F6_ D#$)@[6Q^=:>)WVQ_U*E BH_ZDYX?
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MK-RJY9G>"DRI[^*T]$E[/S5DL*F(,PJLL^?-;<^><]:G4.RN3^_97Z/D'M"
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M&YC^S]3ZK 3S L(A8B/.'[+R(P9=4VD0W6H@LB@-DX%<U?A6]Q$Q06>X(R*
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M_!C_^L329C/PJVWJD45C'O,$'/GH1DA-'BS(2$)()Y>U,U$3.I:/19-<EX=
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M_9DRQ_]([GLK1@]O4.J8G.X&3I>3.,8D!SLHR(76W?Q52//L5NCGF8):)\U
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M9YE5 8*B+Q%EK-(HR.+R%FM#*>'#$\MBBD-/1FD\:F3 F"< X15/,QYE! +
ML\7^A4 Y5 @"FB E9AG#X@=UEDU!4ERE8H+,U^>H9CGXCOM^DL+28"4 3@9P
M^AC 9\257L.4%4I>I25JZX0(V(!FC>5(UAF,7Q0"5"  %F17"GI_7J9E!0]H
MP,= .P!]+(I*;PMIV2R7#-0M.'0 6,[V63%FIQQ>4SF[)-$V0$FYOK_!(O2=
MB1+0S:<E )1*91620:I@<*OW)C >BE&]^2!J8;OU9+3<"%$%YR,#)-Y)?E2T
M&?AB6? 89GJSMKU&?Q<\2>S?VFU$'XTKRSFQ]$_HH\IX4<))L)^. ;*D&N%A
MV?YYUK_U<*_=&DN3-VM_[??W]P]W#Z+!_J"_]W*[?\@/HKW!3I3LQ$?\Z/#0
M]](PYG_&Y:NW[6_PN\2NS2T X+_"<Q7SS((P3I,D$\=K,^\_/O\SFM<,T[-\
MKDINL8BC!2_B=?WV1?F"?8YE!3)FB_T#:*O,!-BK]=M;+PR^ZF[8<FSANR7?
MO<"V+63+*ED\R7HO,2SR#;;LJ> _!T4O3:RP?C]*Q8"=?A5Q33;:I\$@!3WA
M_GOH:UDD0>;H67$&TA/UH&K4\<M_:ZUQCL,)A3S\+Y> &.WC, H3;)(6L)SE
M8BBKE.1BFH-!3\&N^QIE/@9L1 :(P$)IOH&?*SFVN\?BC)?EF[5W%^>_8.3I
MG1+\RPG\7YMR:)K.HUK9IV>O\=>&HCBWP^WAC/,V1\T\:^/;?+?V=B<8[^GB
MJ # -R-<Y"8?5!B>XMD$]*$YF.B>GW#(S8RM$4PQ-K:-<;:64F*4%_,=:"4V
M)->_8TBN0^A=@EB$.UW3YC*&C*ZEW%4XZ?L()]TD#>YLF-PW&R#$$$+6S,U9
M ]H>V>WOO#S8Y]'.]N'NWM'A/M\[B%X>Q/'VWO;.;O(R>01[Y'!AFD5PM\G5
M18J&B9$\0&LZ[#_"VN[MTC$:0N,&$%>H1<7P&C?F-KH*KHVAS406[#/DKXA!
M%;O28P>=+3I6\?3!E;FA.&_=MXK*S5M^SU][KQOE\Y QN\WL&> G$/W;V&*7
MUM';4#^YZY08"*4HB:J)#YH U()#@EL&^F]AP"DY 6:=OUG;6;L]R[("?0Y[
MF#_F-:QB[ICWMT:?&\^%0UD"D?$HS=+J]N;X<^2Y_T*?ID>I%"M$$RT2K(3E
M]EAE5@M'"EA'B1YO_%20RQ@^C*8%:-X";3CX"ZPX_$M-TE(PX-YD$^$/DY$^
MB=&426 ^.E,#&%O&)ZV7>FC!(!0A7D2^< ]8 ))<VQ[;$]K2EN@:I]BPYGDP
M9ID"7KA"US,(E7*+?1QHMWQ5B7%!+R>2G-/:-U^B<QM=+CH40+[>=#P620I+
MS:::0]=@.W+://@&..I I,8=[<$YH_G/)9'5@7^.!]Z$\7##PSOY)%#\:00^
M4.?E=Z#K.>FMQ$P^R*R2YRELN UT&/$W#(;Q. ;3@509EP=DWRLQ.:0&:Z8)
M]P/?>5T'O#!WT &:Q-H3YV6IWVKP?1T6%#+),HD*:$E,!$-C:5ZC=XM]%NHJ
M!9@!'@%\"N-=H#B0Z>5'GN8PCV^R*ZQM&#8T]600G$E#%N6(VRTFQY1FJA9G
M&-G$T&F:ZPP6=![F&*CDI9Q-XOBN,?:ON\DF<\1,7(NMIQLV'$T(KG-$.:!4
M[X()->NX;6L''/;+#O9[,$:&8=5.:IC]S[YHY'][4)4.AT*5%-?-4$OP6(#5
M$N IP2L=J@]#7=2JK-%P:N67S02:>WX8G4U4"HH G,5QD<FI'M[.:'^+ 6LB
M+WDEU=3+&(A$-<$P.VD3>>(C.(0!0A<[&0Q ?805]K3K.S@'Z"I@ H[QB4("
M=YAV4@>[8WG*E\=.=+S_&!]>3Z_?<"(<&+?LY*L4F ,@ZY*R 6*17F$>&5KF
M\%2=51:LJXZ,ZN0 .!IP-.6O)1&:-D3ITOM FU,QK@8&'$H))YT#A^\UF0HH
M/6!9E+! J0ZYS#<1A8 ."M #P]>TJ=,#,02#N3<Y9>2",JHS)>Q0$7J8<?8X
MJQ/M.)@BTQY00"?EJ._WW!RB2K6F*15]5^(6@?U'M&UG":V_E7O&6S3GY:%8
MZJ-\"AY7F%5Y353$<IZ54LE62N4]E,IK'(C7AMS<OBR+WGD>TCLY,M[($TP!
M)?3Z]/A@[O*C*IOOKE4VM]BY J94D;#/,CG1>6AHAB>6/\^F\[%U7%4[:RH'
M'ER!;G"TO:&3H^XP'B8N=Q" #U*^8Y 58M[U/-D,DF&,4E%H#<<)"#_;CA[,
M0)J03/.=O $8?P$V*M73;-!Z68-DT<EC@[!GU=.%%I!S_=Y%WY'D,<LWY(3N
M8!ZAS%U:ZRE7F&RM3Q1FGGOIU]\&K1M,GSJLDT#\>AN^Q3[C-W%K6;B$%J)=
MTAX RK,>'EL0]B4H!MHS'F$-0S[<8J=?*;<0%M4H5;-%"1[%DC[E8R2TZ8WE
MRILZD)F-N*WA&'[[FZ@&MY6FOKR_236XK6RXW9C+N)@E,!%]:^%\UBI$"_)V
MEF$KQS9T-D+G0 1.(24/)S8]VC^$Q]K "5L5UQL53VI3A%;_,#/C46P*:R("
M"HFYZNU.I(D( #"BS?+;BL&L-O  3G13GML=4MI^[$2P<.%_%T<_9"+8XR3"
M+#[[Y;M+:_D@,N"J:MHXH!9H(Y][[L0_M;-L@="TT@J6V!*GR+/Q/?HQ75)4
M; 1:5%6FY7S,RY&ODY>%B$%7L&DIO1F/)7 (H;*IE4WS9HJP9)2(3:>,H-2.
MY@:?G4X$ $BT+K!P",2H<;2VQ>&<@ Z+:@I;@<VM-2C/\@9M1J'EO3MK>9-
M]L<Y;O0@4EU0$4L'L\\Q&<= P2RI%6D?Z,) PQ] :"LJZR<;UB,27#\Z23)
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MMU#\9K.3@=0$R$Q\2PP&0CO932S5O!L$!+.^M9GA)+F?,N6,*6"WH=6_$SD
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M-3$ ZE/=PH78FK^@3I-+GT7"R''5&=5XW7:W-['L4I<?'X>Q0"*MOV$$)VX
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MQ/(K,G3:"=MS5$BMG/1P^9NYK#:GHMILH/6H:WT,"G.M]'1&$1)?-]TV$KI
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M8;]^$<ED2A]&U3B##_\%4$L#!!0    ( #. M5@C'T%W0@,  #8/   1
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M>&<T4=S/'Y9LVB4O[:6=AK4EO!0'Y(_.-Q'Y1_Y(^]/_4$L! A0#%     @
M,X"U6!E<G)\A%@  4)D  !$              ( !     &5F,C P,CDU-3E?
M.&LN:'1M4$L! A0#%     @ ,X"U6&%3WC]:@@  D5@$ !4
M ( !4!8  &5F,C P,CDU-3E?97@Q,"TQ+FAT;5!+ 0(4 Q0    ( #. M5@C
M%//U82(  -OE   5              "  =V8  !E9C(P,#(Y-34Y7V5X,3 M
M,BYH=&U02P$"% ,4    "  S@+58(Q]!=T(#   V#P  $0
M@ %QNP  ;F)T8BTR,#(T,#4R,2YX<V102P$"% ,4    "  S@+58!_#EBGH(
M   P5@  %0              @ 'BO@  ;F)T8BTR,#(T,#4R,5]L86(N>&UL
M4$L! A0#%     @ ,X"U6/1L[;K<!0  [SX  !4              ( !C\<
L &YB=&(M,C R-# U,C%?<')E+GAM;%!+!08     !@ & (H!  ">S0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ef20029559_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nbtb-20240521.xsd" xlink:type="simple"/>
    <context id="c20240521to20240521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790359</identifier>
        </entity>
        <period>
            <startDate>2024-05-21</startDate>
            <endDate>2024-05-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240521to20240521"
      id="Fact_b6dd1f5dec3445bd94bb941f4c456a81">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20240521to20240521"
      id="Fact_383c2a85fcbb41169334f36904c58c0f">0000790359</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20240521to20240521"
      id="Fact_3e0cb6323c684ccb8fe25aea1f31481d">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240521to20240521"
      id="Fact_f3d7b6dfefa1472e93cc3c6ef16ecf30">2024-05-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20240521to20240521"
      id="Fact_41fe7b7ad458440ca75c687a995d9283">NBT BANCORP INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240521to20240521"
      id="Fact_2b65bf96e4724c749ae122cbbefd6dc5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240521to20240521"
      id="Fact_116916a2d46842c3b3902726321be122">000-14703</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240521to20240521"
      id="Fact_8ee18dbbf03d4b43b1fa0d84669469bf">16-1268674</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240521to20240521"
      id="Fact_f4f5bc05263b471db875150b1161f1bf">52 South Broad Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20240521to20240521"
      id="Fact_43ee6b0da5dd4e9f8f7e62764100fecf">Norwich</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20240521to20240521"
      id="Fact_1835f7bf23364f2f9aae89fd9a82c140">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240521to20240521"
      id="Fact_85cf0c58bd5749db88242146f851c671">13815</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20240521to20240521"
      id="Fact_0269ca767f094573bfc5242b5d195703">607</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240521to20240521"
      id="Fact_6d09f6dc82664002b6a1229cf0f314e6">337-2265</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20240521to20240521"
      id="Fact_44b7452af36f4957a7ee3183e9039b1c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240521to20240521"
      id="Fact_3945786da8934dc5a2bbf3593c0eb21d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240521to20240521"
      id="Fact_3858e1ddb73445f5a25220535bd1fd8a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240521to20240521"
      id="Fact_6910fa4411a446d8b5a5f0b75de558ef">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240521to20240521"
      id="Fact_e02ce21253cd4cc791ac0e93983b7937">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240521to20240521"
      id="Fact_b1f0de9bfb13418c957b22f5336cadf5">NBTB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20240521to20240521"
      id="Fact_07288b9acf084110b65cf5b6b2ac371b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240521to20240521"
      id="Fact_6db47367dda74316a87f0106d2073375">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
